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ABSTRACT: 
This thesis describes the mass spectrometric and low-energy induced collision 
analyses of the protonated molecules obtained fro m a series of novel synthetic 
amphiphilic neoglycolipid cholesteryl derivatives using electrospray ionization. It also 
confirms the in s;tu internal elimination of the polyethoxy-spacer linkers occurring with 
the simultaneous formation of a C-glycoside ion-species produced by an intramolecular 
complex ion-molecule reaction occurring in the ionization source interface and in the 
coli is ion cell of the tandem mass spectrometer. 
The novel series of synthetic neoglycolipids described in thi s thesis varied in size 
and composition. They were composed of a similar cholesterol (hydrophobic) head 
covalently attached to a variable length of diffe rent polyethoxy spacers, covalently linked 
to a polar carbohydrate (hydrophilic) head such as 2-acetamido-2-deoxy-P-D-
gl ucopyranosy I or 2 -azido-2-deox y-P-0-gl ucopyranosy I units. 
The novel formation of a different type of [C-glycoside+H-N2f ion-species 
formed during the ES I-MS and ESI-MS/MS analyses of the neoglyco lipid series 
containing the 2-azido-2-deoxy-glucopyranosyl moiety is also described in this thesis. 
The difference in the chemical structures of neoglycolipids affects the low-energy 
induced collision fragmentation and the abundance of the resul ting product ions. Data on 
diasterei omers, anomers and constitutional isomers of the neoglycolipids fragmentation 
were compared to veri fy the presence of the C-glycoside ion species. 
ii 
Finally, the analyses of a series of new synthetic simple glycoli pids, N-acety l-
glycosides and N-glycoside derivatives, which do not contain the cholesteryl aglycon 
portion, were carried out to determine the fragmentation pathway and to observe the 
similarity with the fragmentation pathway of the carbohydrate portion of the studied 
neoglycolipids. 
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Chapter I: Introduction 
1.1. Liposomcs, ncoglycoconjugatcs, C-glycosidcs 
1.1.1. History 
The main goal in medicinal therapy is to be able to target specific cell-functions 
within the body. In the 1970's, it was determined that liposomcs could be used as drug 
carriers. It was believed that a liposome, which could interact with the surface of the 
desired target cell , could be used a a vehicle to carry cell recognition molecule . In 1982, 
most articles regarding liposomes hailed them as a revolution for use as "guided missi les" 
in drug therapy.1 The interest in using liposomes grew into applications as vaccine and 
diagnostic tools. However, problems have been encountered with using liposomes as a 
drug delivery y tern. In fact, "targeting" of liposomes to specific cell in vivo requires: i) 
access to the appropri ate target cell ; and ii) recognition and selecti ve interaction with the 
target cell with little or no uptake by non-target cells. 1 The combination of li posome-drug 
also has to be non-toxic, and stable enough so that the concentration of the drug would 
still be effective when deli vered to the targct. 1 
1 
1.1.2. Liposomcs 
A liposome is composed of a hydrophilic cyclic bilayer of membrane-type lipids 
that fo rm a sphere with an interior hydrophilic compartment. This interior compartment 
contains biological fl uids that allow thi compartment to be a drug carricr. 2.3 Liposomes 
are often used as drug deli very systems due to their encapsulating properties (Figure 1.1 ). 
The encapsulated molecules can be carbohydrates, proteins or even DNA. 
Liposome for Drug Delivery 
Protective layer against 
1mmune destruction 
I 
--, 
Drug crystallized 
in aqueous fluid 
Hom1ng 
peptide 
Lipid-soluble 
drug in bilayer 
Figure 1.1 : Liposome representa tion with enca psulation of drug 
(http://en.wikipedia.org/wiki/Liposome) 
When injected into the body, membrane permeability will be affected. the 
liposome will change its structure, and lysis (drug delivery) will be induced.4 Drug 
carriers can influence drug metabolism, tox icity or drug deli very to pharmacological 
receptors and can also prolong in vivo drug actions. Furthermore. when neoglycoli pids arc 
incorporated into a liposome, liposome life can be increased by half. 5•6 It should be noted, 
2 
however, that other kinds of drug carriers, such as antibodies, proteins, polysaccharides, 
synthetic polymers and other kinds of macromolecules are used for their therapeutic 
effects.7 
1.1.3. Neoglycolipids 
Glycoconjugates are composed of mono-, oligo- or polysaccharide carbohydrates, 
often called glycans,4 connected by a covalent linkage to a protein (glycoprotein) or to a 
lipid (glycolipid).2 These molecules are amphiphilic due to the difference in polarity 
between the polar head (glycan) and the non-polar lipid tail (lipid, protein).8·9 A common 
methodology for using different specific glycoside antigens as medicinal vaccines is to 
encapsulate the carbohydrates inside a liposome. 1 0•11 There are various 2-amino-2-deoxy-
B-glycopyranosides containing specific 0-antigens that have been synthesized for their 
immunochemical and enzymological interests. 12 These can be found in human milk, 
blood, and virulent bacterial lipopolysaccharide antigens.2 Consequently, the 
oligosaccharide moieties of the different glycoconjugates play an important role in the 
human body. They are involved in i) the blood group specificities, ii) extension of the life 
of liposomes by up to one-half in the blood stream, iii) creation of antibodies when a cell 
is invaded by a virus, and iv) enzyme action.2 
Neoglycoconjugates are often found linked to the outer-cell membranes.8 Their 
carbohydrate moiety, which is situated on the cell membrane, can have important 
functions such as cell-cell or cell-virus recognition.2 lt is important to note the utility of a 
spacer in neoglycolipids. According to several studies, the spacer connecting the 
3 
carbohydrate and lipid imparts stability to the molecule by acting as a balance between 
the hydrophilic and hydrophobic parts. 13.1 4 Moreover, thi s spacer facilitates embedding 
into the liposomes14 and into the surface bilayer.6 This oligoethyleneglycol allows easy 
recognition of the head group (key) by the target protein (lock or receptor). 10 These 
modifications of neoglycolipids may allow medicinal use as agents against AIDs, the 
HlV6·15 and cancer.6·14·15·16 In addition, they also can be used as vaccines,6· 16·17·18 and can 
play other roles such as raising antibodies, 17 being used as a bacterial antigen 19 or as an 
inhibitor.3·18 
Some studies have shown that galactosamine can interact with T cells. For 
instance, if N-acetylgalactosarnine is linked to a T cell, it will permit the creation of a 
non-hydrolysable vaccine. 16 Another experiment has shown that whi le a synthetic 
carbohydrate cannot function like a natural one (due to the chemical modifications), its 
effects resemble those of the natural one. John Schmieg et a/. 20 have shown that synthetic 
carbohydrate can mimic T cell activity instead of stimulating it. However, this synthetic T 
cell was inhibiting Th1, even though a natural T cell would produce Th and Th2 cytokines. 
In the case of the neoglycolipids studied in thi s thesis, the cholesterol moiety acts as a 
b b.,. . 21 mem rane sta 1 tztng agent. 
1.1.4. Glycoside derivatives 
There are different types of glycoside derivatives which involve the presence of 
heteroatoms on the anomeric position C- 1 such as C-1-0-, C- 1-N-, and C-1-C-glycosides 
and they are all used in medicine.5·7·15·16 However, in the treatment of HIV and HeY, it 
4 
recently appeared that N- and C-types of glycosides were preferable to an 0-glycosidc in 
some medical treatment.22 While both are similar in their conformations, the C-glycosides 
are chemically more stable than 0 - and N-glycosides.22 Finall y, the various C-
glycosidation reaction have been shown to be much more difficult to achieve than 0-
and/or N-glycosylations.6 
The neoglycolipids studied in thi s thesis present in their structures two types of 
carbohydrate moieties: 2-deoxy-2-N-acety l -~-glucosaminyl and 2-deoxy-2-N-acety l -~­
galactosaminyl. The hydrophobic part of these synthetic neoglycoli pids is a bui ld ing 
block for T and T11 antigens. 14 
1.2. Formation of a C-glycoside ion-species formed by Cl D in the collision cell 
of the tandem MS/MS 
In previous publications,5·23 it was tentatively proposed that a IC-glycosidef ion-
species was formed during electrospray ionization (ES I) by CID in the interface 
atmospheric region of the mass spectrometer and in the collision cell during acq uisition of 
CID-MS/MS, from a series of 2-deoxy-2-amino-~-D-glucosamine- or a 2-deoxy-2-N-
acetyi-~-D-glucosamine-containing neoglycoli pid cholesteryl derivati ve . The rational 
formation of this ~-D- ian-speci es could not be explained from the model of the molecular 
structure of the neoglycolipid cholesteryl derivati ves. 
The chemical structure of this [C-glycoside t ion-species was proposed by 
performing CID-MS/MS of this ions species which produced two major product ions, 
namely, the 2-deoxy-2-acetamido-glucosamine oxonium ion, and a protonated 
5 
cholestadiene. This CID-MS/MS analysis indicated that the precursor [C-glycosidef 
derived from the 2-deoxy-2-N-acetyl-P-D-glucosamine neoglycolipid cholesteryl 
derivatives dissociates by two possible contiguous bond cleavages. 
The first putative mechanism involves the elimination of the axial C-2 hydrogen 
of the sugar moiety, with consecutive cleavage of the anomeric C-1-steoridal C-3' bond. 
This forms the neutral 2-N-acetyl-2-deoxy-D-glucal fragment. The protonated 
cholestadiene observed at m/z 369.15 resulted, presumably, via the C-3'-C-4' double bond 
formation on the steroid nucleus, followed by protonation at the C-6' to produce the 
cholesta-3-ene tertiary carbocation (equivalent to a "protonated" cholestad icne) (Scheme 
1.1 ) . 
6 
neoglycolipid 
[neoglycolipidr 
[C-glycosider 
! 
neutral sugar (glucal) [3,5-cholestadiene] 
J 
protonated cholestadiene 
Scheme I. I: First concerted cleavage mechanism. 
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In the second putative mechanism, it was presumed that the precursor [C-glycosidej 
undergoes the C-1-steroidal C-3' bond cleavage as a result of anchimeric assistance from 
a lone pair of electrons from the ring oxygen. This forms the [Oxoniumj " species which 
can be stabilized by the N-acetyl group which produces the corresponding 1,2-
oxazolinium ion or [Oxazolinium( The C-1-C-3' bond cleavage is facilitated by the 
protonation at C-7' of the eholesta-3,5-diene (Scheme 1.2).23 
8 
neoglyco lipid 
+ 
[ neoglycolipidl ' 
• [C-glycoside f 
+ 
[C-glycoside] ' 
I 
OH 
H~~ 
~) 
H3C 
[Oxoniumr 
1 1 
OH 
Ho~-~­
Ho~..-~-...::,. 
+ NH ro 
H3C 
[Oxazoliniumr 
... 
Scheme 2.2: Second concerted cleavage mechanism 
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[3 ,5-cholestad iene] 
OH 
The rationale proposed for the actual formation of the fC-glycoside] + ion-species, 
was that it re ulted from an ion-molecul e reaction which can occur in both the collision 
cell and within the ES I interface of the Turbo lonspray source. The parent ion produced 
from the chole teryl glycolipid ([M+ I If in Scheme 1.3) wa postulated to undergo 
covalent bond cleavages analogous to tha t proposed for the C ID-M /MS analysis of the 
[C-glyco idct above, in which an [Oxoniumf f--+ [Oxazoliniumf species and a neutral 
cholestadiene is formed, as well as the fragment(s) resulting from the "spacer'' group. The 
[Oxonium 1 +- f--+ [ xazoliniumf ion then undergoes an e lectrophilic addition to the 
cholesta-3,5-diene at the C-3' pos ition of the steroid, which concomitant loss of proton 
from the C-7' po ition and the formation of the C-3 ' C-glycosidic cho lcsta-4,6-dienc 
observed at its corresponding protonated ion. 
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I Oxonium I' 
OH 
\ 0 
IOxazo liniuml+ 
+ 
[ HO 0 0 OHJ '--------.1 \._/ \______J 
13.5-Cholcstadicnc I 
I Reaction occurs inside the co llision cell dur ing MS/MS 
or the interphase of t he ionization sourcc l 
I C-g lycosidc 1·' 
+ 
Scheme I. 2: General scheme for ion-molecule reaction propose to produce the observed IC-
glycoside+H ( ion-species. 
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In the case of the free 2-amino group on the sugar moiety (i.e. glucosamine), the 
electrophile is a 1,2-cyclic-aziridinium ion. The presence of the [C-glycoside] ' ion-
species was not observed; however, when the sugar moiety did not carry the N-acetyl 
derived participating group on the C-2.23 
The C-glyco ide ion-species was believed to be obtained in the gas-phase by an 
ion-molecule reaction, aided by intermolecular forces such as, for example, ion-dipole. 
Campbell eta/. 24 demonstrated that an ion-molecule reaction occurred when screening the 
amido functionality with Fourier transform cyclotron resonance (FT-ICR). These rapid 
and spontaneou reactions are the most common ones for protonated molecules. They 
suggest that a proton transfer and a nucleophilic substitution occurred at the same time 
due to the endothermicity of the proton transfer step. It was also observed that the 
aromatic ring is essential for this reaction to occur. Finally, they obtained the same results 
using a triple quadrupole mass spectrometer as the ion source. 
A literature survey revealed that gas phase CID-MS/MS fragmentations, under 
any different type of ionization is a unimolecular process. In addition, it has also been 
revealed that many ion-molecule reactions occur via mechanisms med iated by 
intermediate complexes, ranging from simple electrostatically or hydrogen-bonded 
species to covalently bonded complexes?5 
As Liu and Anderson25 stated: "Evidence for the role of complexes includes 
isotopic scrambling, forward- backward symmetric product angular distributions, and 
product branching and recoil energies consistent with stati tical unirnolecular decay of a 
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long-lived intermediate. In such reaction , it is safe to say that the breakup of the complex 
is a statistical process, signify ing that it depends only on the total energy and angular 
momentum of the complex." 
FUJthermore, it has been reported that even for reactions mediated by a stati sti ca l 
complex, the reaction may be controlled by dynamics, i.e., the rate-limiting step is 
sensitive to the details of reactant preparation, not simply on energy and angular 
momentum? 5 
Liu and Anderson25 also cited that: "The fundamental assumption, in stati stical 
reaction models, is that energy is randomized, i.e., distributed stati tically among all the 
energetically accessible states of the system. For stati stical factors to control reaction, thi s 
randomization must occm prior to the rate-limiting step in the mechanism.26·27·28 Inherent 
in this assumption is the requirement that energy exchange between different degrees of 
freedom be facile, so that energy randomization can be rapid compared to the reaction 
time. In addition, the rate of a particular process (e.g, breakup of a complex, or 
interconversion between different complex isomers) is proportional to the total number of 
energetically accessible states (subject to angular momentum conservation) at the 
transition state (TS)." 
Fukui stated that "statistical reactions tend to occur by paths close to the minimum 
energy path, as the density of states is highest for such paths."25·29 To predict the 
behaviour of statistical mechanism, the energies, moments of inertia and vibrational 
frequencies for the complexes and transitions states that connect the reactants to various 
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product channels have to be calculated.25 ' 'For many ion-molecule reactions, there arc no 
energy barriers to the approach of reactants, thus it is assumed that the initial ion-
molecule complex forms effi ciently".25 The unimolecular rates for crossing the various 
transition states leading from the initial complex to other complexes as well as various 
product channels, are calculated u ing the transition-state-theory-based model such as the 
30 ' I 26 Rice-Ramsperger-Kassei-Marcus (RRKM) theory .J or phase space theory. Baer and 
Hase26 realized that " the product branching is given by the ratio of the rates, and recoi I 
energy distributions can also be calculated based on the assumption of stati stical energy 
partitioning in the products. This basic approach has been successful in accounting fo r 
[their] many experimental observations, and these successes upport the assumptions 
made in the statistical models." 
chranz and Sewell32 demonstrated that detailed investigations of dynamic effects 
on chemical reactions, leads to reconsideration of the validity of the fast-energy exchange 
assumption inherent in the statistical approach. Reacting molecules might not necessarily 
follow the minimum energy pathway when kinetic energy is accounted fo r. 33·34 These 
phenomena would be due to the relationshi p between intra-molecular vibrational 
redistribution (IVR) and molecular tructure.33.34 Finally, Liu and Ander on25 reported 
that in previous experiments "non-statistical effects have been seen in the variation of 
unimolecular lifetime with energy,35 .36 in product energy distributions,37·38 product 
branching ratios,39 and in the effects of electronic40 and vibrational excitation."41 
Therefore, after careful considerati on, it was deemed probable that the CID-
MS/MS C-glycoside ion-species fo rmed might be produced from an ion-molecule 
14 
reaction occurring through an electrostatically bound transition complex, contro lled by 
intramolecular forces. This presumes that during the " interna l elimination" of the spacer, 
the activated complex transition state contains the positive I ,2-ozazolinium ion and the 
neutral molecule which are held in very close proximity by an electrostatic fo rce which, 
in turn, almost certainly produces a covalent bond . 
During this M.Sc. work , it became possible to rationali ze that th is unique and 
novel C-glycoside ion-species was formed by an " intramolecular" mechanism . 
Future explanations for this phenomenon may result when com plex gas-phase 
reactions of this described type are fu rther explored. For these reasons, it was d ifficult to 
correctly name thi s product ion as: i) a covalent C-glycoside product ion or ii ) an ion-
molecule complex he ld by strong electrostatic fo rces. For simplicity, it was decided to 
call it the "C-glycoside" ion-species, as its molecu lar mass corresponds to that of the C-
glycos ide ion. 
Therefore for expediency purposes, throughout this M.Sc. thesis, any fo rmation of 
novel ion-molecule reaction species formed in the vacuum interface o r the colli sion cell 
during CID analyses will be referred to as the "C-glycoside" ion-species. 
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Chapter 2: Experimental 
The thesis deals with the experiments conducted by conventiona l ES I-MS and low 
energy C ID-MS/MS on a novel synthetic neoglycoconjugate serie , namely. 2-acetamido-
2-deoxy-~-0-gl ycosyl -containing neoglycolipids (Chapter 3 and Chapter 6), per-0 -
acetylated 2-acetamido-2-deoxy-~-0-glycopyranosyl neoglycolipid derivati ves (Chapter 
4), 2-azido-2-deoxy-~-0-galactopyranosyl neoglycolipids and thei r partia ll y acetylated 
deri vatives (Chapter 5 and Chapter 6), and a series of simple glycolipids containing 2-
deoxy-2-N-acetyl or 2-deoxy-2-amino-glucosaminyl residues (Chapter 7). 
These experiments were conducted to confirm the purity of the neoglycolipids and 
g lycolipids using mass spectrometry techniques. It was reported earlier that the 
neoglycolipids can facilitate the stability and gene transfer ability o f liposomes.42-"3 
Structural studies o f liposomal formulations and liposomal-gene carrie rs are necessities 
for the pharmaceutical and the rapeutic fte lds.23 These neoglycolipids were synthesized by 
anothe r laborato ry (Laboratoire de Chimie Organique II , Glycochimie, Uni versite C laude 
Bernard, Lyon-France) and were characte rized using the following techniques: column 
chromatography, polarimetry, thin layer chromatography and nuclear magnetic resonance 
spectroscopy. 
16 
10) 
2.1. Synthesis 
2.1.1. Synthesis of 2-acetamido-2-deoxy-glycosyl-containing glycolipids (1-4, 9-
OH 
HO :\ _\. O\ 
HO~O \ _ _;\ __ / 
NHAc ~ 1 D-GicNAcE3Chol 
HO~O~o· HO~NHAc 
OH 
~o ~o, 
2 L-GicNAcCho l 
HO~o~ 
OH NHAD 0 0 0 
\_)\_/\_/ 3 DGaiDGaiNAcE3Chol 
Figure 2.1: Structures of free-acetylated neoglycolipid cholesteryl de riva tives 1-4 
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CHMe 2 
The synthesis of 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-
~-0-glucopyranoside (O-GicNAcE3Chol) 1 (Figure 2.1 ) was previously reported and thi s 
molecule was synthesized for its efficacy against bacterial infections. 10.44 8-(Cholest-5-en-
3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-~-D-galactopyranosyl-a-D-
galactopyranoside (D-Gai-O-GaiNAcE3Chol) 3 (Figure 2.1 ) was synthesized following 
the protocol of Boullanger et a/.45·46 Cholest-5 -en-3-~-yl-2-acetam ido-2-deoxy-~-L-
glucopyranoside (L-GlcNAcChol, L-N-acetyl-glucosamine-cholesteryl) 2 (Figure 2.1) 
was synthesized according to the procedure of Lafont and Boullanger.47 The deprotected 
2-acetamido-2-deoxy-L-glucoside-0-acetylated-cholesteryl derivative was deacylated and 
deprotected using a catalytic amount of sodium methox ide (MeONa) in methanol 
(MeOH) (Scheme 2.1). 
Aco....._ \0 \ 0 
AcO~ NHAc 
OAc 
2-acetarrido-2-deoxy-L-glucoside 
MeONa (cat), Me0H,93-95% HO......_ \ 0 \ 0 
HO~ NHAc 
OH 
Cholesteryl-5-en-3-p..yt-2-acetarrido-2-deoxy-IJ..L-glucopyranoside 
2 
Scheme 2. I: The synthesis of molecule 2 according to Lafont and Boullanger 47 
The use of the molecule 11-(cholest-5-en-3-~-yloxy)-3,6,9-trioxaundecyl-a-L-
fucopyranoside (L-Fuc-E4Chol) 4 (Figure 2.1) was reported by Bardonnet et a/: 10 
however, the synthesis of the compound was not described. 
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HO~O HO~O 
NHAc 9 p-GicNAcChol 
tLo OH HO~o~O 1\f\f\ 
OH HO~o o o 0 
NHAc 
Figure 2.2: Structures of neoglycolypid cholesteryl derivatives 9-10 
10 l.acNi\ci '.,Chol 
The neoglycolipids cholest-5-en-3 -~-y 1-2-acetam ido-2-deox y-~-D-
glucopyranoside 9 (Figure 2.2) (~-GicNAcChol) and 8-(cholest-5-en-3-~-yloxy)-3 ,6-
dioxaoctyl-2-acetamido-2-deoxy-4-0-~-D-galactopyranosyi-~-D-glucopyranoside 10 
(Figure 2.2) (LacNAcE3Chol) were synthesized by Boullanger el a/ according to a 
previously reported procedure. 19• 45 
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2.1.2. Synthesis of per-0-acetylated-2-acetamido-2-deoxy-D-glycopyranosyl 
neoglycolipids (5-6) 
~OAc OA OAc 0 ~ AcO 0 
OAc NHAD 0 0 0 
\___/ \_/ '\._____) 
6 LGicN/\cChol 
Figure 2.3: Structures of per-0-acetylated cholesteryl neoglycolipid derivatives 5 and 6 
The synthesis of 8-( cholest-5-en-3-~-y loxy )-3 ,6-dioxaoctyl-2-acetam ido-4,6-di-0-
acety 1-3 -0-(2,3 ,4 ,6-tetra-0-acety 1-~-D-galactopyranosy 1)-2-deox y-a-D-
galactopyranoside (D-Gai-D-GaiNAcE3Chol) 5 (Figure 2.3) and the cho lest-5-en-3-~-y l -
2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-~-L-glucopyranoside (L-G icNAcChol) 6 (Figure 
2.3) were achieved according to methods reported by Lafont et a /.45·47 
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2.1.3. Synthesis of 2-azido-2-deoxy-P-D-galactopyranosyl neoglycolipids (7-8, 
11-12) 
):' 
OA OAc tLo Aoo~o~o o o o 
OAc N3 ~ \_} \_) 
~OAc OH OH 0~ AcO o 
OAc N 
3 0 0 0 0 
\___J \_) \____/ 
8 DGaiDGaiN 1E1Chol 
CHMe2 
12 P-DGal F,Chol 
Figure 2.4: Structures of azido cholesteryl neoglycolipid derivatives 7, 8, II and 12 
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The 2-azido-2-deoxy-~-0-galactopyranosyl residue was attached to the 
neogl yeo I i pids 8-( cho lest-5-en-3 -~-y loxy )-3 ,6-d i oxaoct yl-3-0-(2,3 ,4,6-tetra -0-acet y 1-~-
0-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-~-0-galactopyranoside (0-Gal-
O-GalN3E3Chol) 7 (Figure 2.4) and 8-(cholest-5-en-3-~-yloxy)-3 ,6-dioxaoctyl-3-0-
(2,3,4,6-tetra-0-acetyl-~-0-galactopyranosy l)-2-azido-2-deoxy-a-0-galactopyranoside 
(O-Gai-O-GalN3E3Chol) 8 (Figure 2.4), according to the method reported by Laurent el 
a/.14 
The molecules 8-( cho lest-5-en-3 -~-y loxy )-3 ,6-d ioxaocty 1-2 -azido-4 ,6-0-
benzylidene-2-deoxy-a-0-galactopyranoside (a-0-GaiN3E3Chol) 11 (Figure 2.4) and 8-
(cholest-5-en-3-~-yloxy)-3 ,6-dioxaoctyl-2-azido-4,6-0-benzylidene-2-deoxy-~-0-
galactopyranoside W-O-GaiN3E3Chol) 12 (Figure 2.4) were also reported previously, and 
were synthesized from I 0 I . I I . . d 14 a N-acety -a- -ga actosamme neog yeo 1p1 . These 
neoglycolipids contained the same saccharide (0-galactosamine-azido-0-galactosamine 
(OGalOGaiN3)). However, the presence of the 4,6-di-0-benzylidene group was present 
for 7 but not for 8. 
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2.1.4. Synthesis of simple glycolipids (13-15) 
OH 
HO~O HO~O-CaH17 
NHAc 
14 GlcNAcC8 
Figure 2.5: Structures of s imple glycolipids 13-15 
The synthesis of 13, a 1 -ethoxy-[2-2-ethoxy]-dodecanoxyi-2-N-acetyl-2-deoxy-~-
0 -glucopyranoside (GicNAcE3C 12) wa accomplished by Boullanger et a/. ;46 however, 
the cholesterol tosylate was replaced by an ali phatic a lcohol. The synthesis of 14, an 
octanoxyi -2-N-acetyl-2-deoxy-~-0-glucopyranoside (GicNAcCs) and 15, a 1-
undecyloxyl -2-amino-2-deoxy-~-0-glucopyranoside (GlcNH2C 11 ) was consistently the 
same for the first step, according to Boullanger el a/.19 Compounds 13, 14 and 15 are 
shown in Figure 2.5. The I ,3,4,6-tetra-0-aeety l -2-amino-2-deoxy-~-0-glucopyranose 
hydrochloride "a" (Scheme 2.2) was used for the synthesis of the I ,3,4,6-tetra-0-acetyl-
2-deoxy-2-acetamido-~-0-glucopyrano e "b" (Scheme 2.2) which was used as the 
g lycosyl donor for the synthesis of the compound "c" (Scheme 2.2). 
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OAc (' Ac~O\ (CI-!.JCO)p,pyr 
AcO~OAc 
N~·.cr 
a 
(""OAc 
NHAc 
b 
Scheme 2. 2: Scheme for the synthesis of molecules 13 to IS 
OAc 
NHAc 
c 
Boullanger et a/. 19 de-0-acetylated the ammo glucolipid "c'' to obtain the 
molecule 14 (Scheme 3). To obtain the molecule 15, the same procedure was applied, 
followed by heating the amino glycolipid in a concentrated aOH solution (Scheme 2.3). 
14 
NHAc 
MeONa, MeOH 
OAc 
NHAc 
c 
15 
Scheme 2. 3: Oeacylation of molecule 12 
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2.2. Instrument Methods 
2.2. 1. ESI mass spectrometry 
The mass spectra of a ll neoglycolipids were acquired in the positive ion mode 
usmg an Applied Biosystems A PI-QSTA R XL quadrupole orthogonal time-of-flight 
(QqToF)-M S/MS hybrid tandem mass spectrometer (Applied Biosystems lnternationai-
MDS Sciex, Foster C ity, Califo rnia, USA). This instrument is capable or analyzing a 
mass range of m/z 5 to 40,000, w ith a resolution o f I 0,000 in the positive ion mode. ESI 
was performed with the Turbo Ionspray source operated at 5.5 kV and a tem perature or 
I 00°C. Each neoglycolipid was dissolved in 250 IlL of methanol (MeO I-1) fo r the 
injection. The aliquo ts were infused into the mass spectromete r system using an 
integra ted Harvard syringe pump (Quebec, Canada) at a rate of 5 11Limin . The ToF 
analyzer was calibrated using a Pep-Tyf prote in which was di ssolved in a I : I mixture or 
acetonitrile (ACN or CH3CN )-water ( I-120) and checking fo r the exact masses of the 
rM+Ht at m/z 163 8.8485 and [M+ I-1]2 at m/z 81 9.9279 . 
2.2.2. Low-energy CID-MS/MS 
The product ions spectra were obta ined from fragmentation in the rad io- frequency 
(RF), linear acceleration pulsar hi gh pressure (LfN AC) equipped, q uadrupole collision 
cell of the QqToF-MS/MS hybrid instrument. The coll ision gas used fo r MS/MS analyses 
was nitrogen. The collision energy (CE) and the C ID gas cond itions ensured that the 
precursor ion remained abundant. A seri es of second-generatio n ES I-C I 0 -QqToF-
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MS/MS experiments on the diagnostic product ions was conducted to re-confirm the 
various establi shed fragmentation routes. These ES I-CID-QqTOF-MS/MS experiment 
were initiated by CI D in the atmospheric pressure/vacuum interface using a higher 
declustering potential (DP). It was reported in previous research that increasing the DP 
· n d h · b · · h · 1 " fi · f h d 23 .Jx 49 111 . uence t e ton count, y ratsmg t e "m-nozz e ragmentatton o t e compoun . -· · 
In that context, it is emphasized that low energy-collision-induced dissociation (C ID) 
spectra are usually obtained by MS/MS: the parent ion is selected, collided with a neutral 
gas, and the fragment ion spectrum i recorded. 
However, it was recognized very early that colli ional di sociation could be 
induced in the electrospray source by increasing the diffe rent acceleration voltage . 
Di fferent names for this process have been given by users and manufacturers: nozzle-
skimmer fragmentation, cone-voltage fragmentation, skimmer-CID, etc_ 
In the pre ent study, this will be referred to a ' ·source- ID." The disadvantage is 
that the parent ion is not selected. Rather, all ions emitted by the electrospray source 
undergo coli isional acti vation, and all the fragments are collected in the same mass 
spectrum. Sourcc-C ID avoids any requirement for real-time data-dependent scanning 
software, as required for automated M /M . A simple ramp of voltage can be applied 
between the different skimmers and lenses to produce varying amounts of fragments 
during analyte elution. 
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2.2.3. Product ion scanning experiments 
Tandem mass spectrometry analyses were conducted to determ ine the 
fragmentation pathways leading to the fo rmation of the various product ions observed in 
the conventiona l mass spectra obtained from each neoglycoli pid. T hese analyses were 
carried out under low-energy. 
For the product ion scan analyses, the fi rst quadrupole (Q1) selected the 
corresponding precursor ion and it generated product ions by collision with N 2 gas in the 
(RF-only) quadrupole (Q2). The third mass resolving ti me-o f- fli ght analyzer (ToF) 
scanned the m/z values to determine the occurrence of particular product ions previously 
fo rmed in the 02-
2.2.4. CID-MS" or quasi MS 11 analysis 
T he C ID-MS/MS experiments were accomplished by selecting a precursor ion from 
the previous scan analysis. Quasi MSn product ion scans are ini tiated by C ID in the 
atmospheric pressure/vacuum interface using a highe r declustering potential. It has been 
assumed that when a first generation product ion, formed by a conventional C ID-MS/MS 
ana lysis, was selected fo r a product ion scan analysis, then the analysis of thi s selected 
ion was presumed to be a quasi-MS3 analysis, which would be known as a second-
genera tion ClD-MS/MS analysis. In this thesis it has been shown, in fact, that a quasi-
MS3 or second generation product ion scan conducted with a QqToP-MS/MS hybrid 
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instrument is similar to a conventional MS3 experiment conducted with a QIT-MS11 or FT-
ICR-MS11 (Chapter 5). 
2.3. ESI-MS and ESI-MS/MS analyses of the different series of neoglycolipids 
2.3.1. Analysis of a new series of 2-acetamido-2-deoxyglycosyl-containing 
neoglycolipids (1-4) 
The gas settings (GS I and GS2) for the full scan analysis of 8-(cholest-5-en-3-P-
yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-P-D-glucopyranoside "1" were kept constant 
at 30 (the flow conversion table is represented in Appendix 1), the declustering potential 
(DP) was I 00 V and focusing potential (FP) was 150 V, and the low collision energy 
varied from I 0 to 15 eV. In the case of the cholest-5-en-3-P-yl-2-acetamido-2-deoxy-P-L-
glucopyranoside "2," the gas settings were the same as those used for 1; however, the DP 
was changed to 300 V and the FP to 200 V. For the acquisition of the tandem mass 
spectrometry data, the DP was changed to 250 V, FP remained the same, and the collision 
energy was 15 eV. 
The full scan settings used fo r 8-(cholest-5-en-3-p-yloxy)-3,6-dioxaoctyl-2-
acetamido-2-deoxy-3-0-P-D-galactopyranosyl-a-D-galactopyranoside "3" were the same 
as "1 ," and the colli sion energy wa kept constant at 15e V. Finally the settings used to 
analyze 11 -(cholest-5-en-3-P-yloxy)-3 ,6,9-trioxaundecyl-a -L-fucopyranoside "4" were 
DP: 300 V, FP: 250 V and CE: 15 eV. 
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2.3.2. Analysis of a new series of 2-acetamido-2-deoxy-0-glycopyranosyl per-0-
acetylated neoglycolipids (5-6) 
The GS I and GS2 settings were kept at 30 for both experiments; however, the 
deelustering potential was kept at I 00 V for the 8-(cholest-5-en-3-~-yloxy)-3,6-
dioxaoctyl-2-acetamido-4,6-di-O-acetyi-3-0-(2,3,4,6-tetra-O-acetyi-~-D­
galactopyranosyl)-2-deoxy-a-D-galactopyranoside "5" and at 200 V for the cholest-5-en-
3-~-yl-2-acetan1 ido-3 ,4 ,6-tri-0-acetyl-2-deoxy-~-L-glucopyranoside "6". The focusing 
potential was at 100 V for "5" and 150 V for "6". The collision energy parameters were 
15 eV for molecule "5" and 10 eV for molecule ''6". 
2.3.3. Analysis of 2-azido-2-deoxy-P-D-galactopyranosyl neoglycolipids (7-8, 
11-12) 
The settings used to acquire the spectra of the 8-(cholest-5-en-3-~-yloxy)-3 ,6-
d ioxaocty 1-3 -0-(2,3 ,4,6-tetra-0-acety 1-~-D-galactopyranosyl )-2-azido-4 ,6-0-
benzylidene-2-deoxy-~-D-galactopyranoside "7" and the 8-(cholest-5-en-3-~-yloxy)-3,6-
d ioxaoctyl-3 -0-(2,3 ,4,6-tetra-0-acety 1-~-D-galactopyrano yl )-2 -azido-2 -de ox y-a-D-
galactopyranoside "8" were kept constant at DP: I 00 V, FP: 150 V, DP2: 5 V (changed to 
5 and 10, in the case of "7"), while CE varied from 10 eV for 8 to 20 eV for 7. For "1 1" 
and "12", the cell collision energy varied between 10 eV and 15 eV. 
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2.3.4. Analysis of simple glycolipids (13-15) 
The spectra of simple glycolipids 13 to 15 were acq uired by keepi ng the GS I and 
GS2 gas settings constant at 30, the temperature at 80°C, the DP at I 00 V, FP at 50 V and 
the CE at 10 eV. 
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Chapter 3: Analysis of a series of new 2-acetamido-2-deoxy-g/ycosy/-containing 
neoglycolipids 
Liposomes are often used for drug delivery and transformation or transfection of 
DNA due to their abi lity to target cancer cells. In this work, neoglycolipids were studied 
since they are stabi liz ing agents for cationic liposomes. The use of cationic liposomes for 
diagnostic and therapeutic purposes is a novel concept. 5° 
Cationic liposomes are considered good gene carriers51 and are often used in gene 
therapy for their powerful capacity to condense DNA and their high transgenic expression 
properties. 52 Although they present a low transfection efficienc/3•54 , they have several 
55 56 . . S4 d I . . . 'i4 'iS 
advantages such as their effectiveness;· · non-toxtctty· an ow tmmtmogentctty: ·· · 
There are also other fields that use cationic liposomes (agronomics, marine 
biotechnology). 57 Their use in cancer therapy has evolved to the second phase of clinical 
studies. 58·59 
3.1. Free neoglycolipids analysis results 
The neoglycolipids in this study contain diffe rent mono or disaccharide moieties, 
namely: 2-acetamido-2-deoxy-3-0-~-D-galactopyranosyl-a-D-ga lactopyranoside in 3, 2-
acetam ido-2-dcoxy-~-D-glucopyranoside in 1, 2-acetamido-2-deoxy-~-L-glucopyranoside 
in 2, and a-L-fucopyranoside in 4. The molecules discussed in this chapter arc 
represented in Figure 2.1 . 
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3.2. 8-(Cholest-S-en-3-P-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-p-D-
glucopyranoside (1) 
In thi s study a solution of the highly purified neoglycolipid 1 mixed to methanol 
was introduced by injection into the e lectrospray ionization source, w ithout any need for 
prio r chromatographic separation. Accordingly, the protonated molecules [M+ Hf and the 
major fragment ions (formed in-source) obtained with the high resolution QqToF-MS 
hybrid instrument, were free from any trace- level analytes e luting from an II PLC. 
together w ith a lot of matrix background that could give ri se to mass multiplets. 
3.2.1. QqTOF-MS analysis 
The structure of the 8-(cho lest-5-en-3-~-y loxy)-3 ,6-dioxaocty l-2-acetam ido-2-
deoxy-~-0-glucopyranoside neoglyco lipid allows the observation of fragment ions such 
as the sodiated [M+Nat at m/z 744.4780, resulting from the protonated mo lecule [M+ Hf 
at m/z 722.4983. Conventiona l analysis of the molecule "1" revealed the presence of the 
1,2-cyclic sugar oxonium ion [DGlcNAc l1 at m/z 204.085 1. The cyclic sugar ion is an 
oxazolini um ion, with a positive charge delocalized on the N-C-0 atoms. This sugar 
oxonium will be referred to as the sugar roxoniumt ion throughout the thesis. 
Formation o f the expected cholesteryl ion assigned as [ ho lestadi ene+ H] r was 
observed at m/z 369.3399. 
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An additional elimination originating from the sugar oxonium ion, the lDGicNAc-
2H20-CH30Ht was observed mlz 138.0450. Eliminations from the protonatcd molecule 
were also observed and can be summarized as ions resulting from lo es of molecules of 
water and methanol designated as [M+H-2H20-CH30Ht at mlz 138.0450. Subsequent 
elimination of molecules of water and ketene was observed for the fragment ion [M+H-
2H20-CH2COf at m/ z 126.4294 (Figure 3.1 ). These losses can be e ither "concerted" or 
"consecutive" according to Banoub el a/. 60 Likewise, it should be noted that, in that 
context, the "concerted" or "consecutive" losses from the different product ions in the 
MS/MS experiments, simply means that the molecules are both lost at the same time and 
within the same reaction region of the hybrid tandem mass spectrometer. 
It has been presumed that the fragment at m/z 572.4106 i the suspected C-
glycoside ion-species, which is formed by an ion-molecule complex reaction based on 
previous work. 5·23 
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Figure 3.1: Full scan analysis of 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acctamido-2-deoxy-~-D­
glucopyranoside ncoglycolipid-molecule " I". 
3.2.2. CID-MS/MS analysis of the protonated molecule 
To confirm the gas-phase fragmenta tion pathway and the fo rmation o f these 
fragment ions, a low-energy collision tandem mass spectrometric ana lysis was fi rst 
performed by selecting the precursor protonated molecule [M+H( Thi s MS/ MS analysis 
y ie lded the expected product ions, which were observed during the full scan ESI-M 
analysis (Figure 3.1 ). New product ions [G icNAc-rhOt at m/z 186.46 and [GicNAc-
2 1-120 ]" at m/z 168.44 were observed. It was characterized as be ing fo rmed by eliminati on 
of mo lecules o f wate r from the GlcN Ac oxonium. The mlz 288.47 fragment remains 
unidentified (Figure 3.2). The ion suspected to be a C-glycosidc ion-species was 
observed at m/z 572.62 at 2.0779% (Figure 3.2, Table 3.1 ). 
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Figure 3.2: CID-MS/MS of the prot.onated molecule 1 M+H (of (8-(cholest-5-en-3-~-yloxy)-3,6-
dioxaoctyl 2-acetamido-2-deoxy-~-D-glucopyranoside), molecule " I" , CE= ISeV. 
Table 3. I: Relative intensity and m/z values obtained for each product ion from the product ion scan 
(CID-M S/MS) of the protonated molecule of 1 M+H 1+ "I ". 
I on Relative m/z 
intensity 
(%) 
[M+H( 23 .90 722.55 
[C-glycoside+H( 2.08 572.62 
[Cholestadiene+H( 1.04 369.68 
[GicNAcSpacer+H( 3.38 354.53 
[DGicNAcJ+ 100.00 204.47 
[GicNAc-H20( 1.82 186.46 
[GicNAc-2H20t 1.30 168.44 
IDGicNAc-2H20 -CHJOH( 0.78 138.42 
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The Scheme 3.1 proposed a fragmentation pathway of the protonated molecule, 
issued from the results obtained during the full scan analysis, and the low-energy colli 10n 
tandem mass spectrum. 
r 
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Scheme 3. I: Proposed fragmentation pathway of 8-( cholest-5-en-3-11-yloxy)-3,6-dioxaoctyl 2-
acetamido-2-deoxy-P-D-glucopyranoside, molecule" I" 
3.2.3. Formation of a C-glycoside ion-species 
The ion su pected to b a C-glycoside ion-species was observed during 
conventional scan analysis of 1, as well as during the CID-M /M of the protonated 
molecule. Third-generation tandem mass spectrometry analysis (quasi-MS4) of the ion at 
m/z 572.62 was performed to confi rm the structure of thi s C-glycosidc ion-species. 
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When the collision energy (CE) was set at I 0 eV, two ions were observed. These 
were the [Cholestadiene+Ht and the [Oxoniumr ions. However, when the CE was 
increased to 15 eV, the presence of other ions, in addition to those cited above. were 
observed, confirming that adjusting the CE affects the abundance of the product ions. In 
fact, an ion was obtained at m/z 556.53, which was assigned as [C-glycoside-CH3 ( This 
CH3 radical loss could arise from the NHAc (amino acetyl) group or directly from one or 
the methyl groups attached to the cholestadiene. The observation of further elimination 
from the C-glycoside ion-species is actually a new finding. The product ion fDGlc Ac-
H20t, arising from the [0-GlcNAct by los of a molecule of water, was noticed at ml :::. 
186.47. Finally, ions observed at m/z 2 14.46 and m/z 408.4 1 were not identified (Figure 
3.3). 
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Figure 3.3: Qmrsi-MS3 of the ion-species IC-glycoside+H I+ arising from 8-(cholest-5-en-3-~-yloxy)-3,6-
dioxaoctyl-2-acetamido-2-deoxy-P-D-glucopyranoside, molecule" I ". 
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3.3. 8-(Cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-~-0-
galactopyranosyl-a-D-galactopyranoside (3) 
3.3.1. QqTOF-MS analysis 
The sodiated molecule [M+Naf at m/z 906.4690 was observed during the full 
scan analysis of the 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-
~-D-galactopyranosyl-a-0-galactopyranoside. The [M+Hf at m/z 884.5172 and the 
[M+ H-DGalf at m/z 722.6374 were also observed, as were the disaccharide [Sugar]* 
moiety at mlz 366.5336 and the monosaccharide oxonium commonly known as 
[DGaiNAcf oxonium ion at m/z 204.5298 observed. The ion at m/z 572.6992 was 
suspected to be a [C-glycoside+H-DGalf ion-species or a [C-glycoside2+H] ion-species 
(data not shown). 
3.3.2. CID-MS/MS of the protonated molecule 
The product ion scan of the [M+H t ion confirmed the presence of the ions 
previously seen in the conventional full scan. Two product ions at m/z 330.53 and m/z 
144.10 were observed and these were assigned as the [Sugar-2H20t and [DGaiNAc-
2H20-MeOHt, respectively. These two product ions appeared also as fragment ions 
during the ESI-MS conventional scan analysis. The presence of the suspected [C-
glycoside+Hf ion-species at m/z 734.61 and the [C-glycoside+H-DGal( ion-species was 
noted (Figure 3.4, Table 3.2). It was realized that the el iminations of the neutrals from 
these product ions can be either "concerted" or "consecutive" as previously discussed. 
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Figure 3.4: CI D-MS/MS of the protonated molecule I M+H ( of the 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-P-D-
galactopyranosyl-u-D-galactopyranoside, molecule"3" . 
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Table 3. 2: Relative intensity and mlz values of the different product ions derived from the CID-
MS/M S analysis of the 8-( cholest-5-en-3-~-yloxy)-3,6-d ioxaoctyl-2-acetam ido-2-deoxy-3-0-~-D­
galactopyranosyl-a-D-galactopyranoside, molecule "3". 
I on Relative m/z 
intensity 
(%) 
[M+H( 92.52 884.52 
[C-glycoside+H ( 2.49 734.6 1 
(M+H-DGal( 6.73 722.63 
[C-glycoside+H-DGal( 0.50 572.67 
I SugarSpacer( 5.99 5 16.53 
I Cholestadiene+H )+ 0.25 369.73 
(Sugar( 100.00 366.53 
(OxoniumSpaccr(+ 3.99 354.58 
(Oxonium(+ 7.23 204.53 
( Oxonium-H20 I+ 1.50 186.53 
Scheme 3.2 below repre ents the possible fragmentation pathway of the 
protonated molecule lM+Ht focuses on the results obtained during the full scan 
analysis, as well as the results from the tandem mass spectrometry analysis. 
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Scheme 3. 2: Proposed fragmentation pathway of the 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-~-D-galactopyra nosyl-a­
D-galactopyranoside, molecule "3". 
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3.3.3. Formation of the IC-glycoside( and IC-glycoside+H-DGal( ion-species 
The econd-generation tandem mass spectrometry analysis or quasi-MS3 of the 
precursor IC-glycoside+Ht ion-species at m/z 734.6 1 wa performed under the amc 
conditions a the low-energy colli sion tandem mass spectrometry of the protonated 
molecule l M+Hf. Therefore the precur or ion at m/z 734.61 produced the [Gic Ac I+-
oxonium at m/z 204.52 and the [Cholestadiene+Ht at m/z 369.74. J\n add itional product 
ion was formed at m/z 186.51 resulting from the loss of water from the ugar oxonium ion 
at m/z 204.52. Additional elimination from the sugar oxonium ion ha e been initially 
reported for another eries of neoglycolipids.23 Note that two other ions were also seen at 
m/z 375.64 and m/z 244.57. These were respectively assigned a [Cholcstadiene+CI!Jf 
and [DGaiNAc+C3H3+Ht ions (Figure 3.5). 
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Figure 3.5: Second-generation tandem mass spectrometry or quasi-MS3 of m/z 734.37, of the 8-
( cholest-5-en-3-~-yloxy )-3,6-d ioxaocty 1-2-aceta m ido-2-deoxy-3-0-~-0-ga lactopy ra nosyl-a-0-
galactopyranoside, molecule "3". 
It is interesting to note that another type of C-glycoside ion-species at m/z 572.67 
was formed in this analysis. This was assigned as the new [C-glycoside+H-DGalt ion-
species, which was present during the conventional full scan and the CID-MS/MS of the 
protonated molecule. However, this ion was not present in the ClD-MS/MS of the [C-
glycosidet ion-species. 
The ion suspected to be a [C-glycoside+H-DGait ion-species, observed at mlz 
572.67, was isolated in a second-generation, or quasi-MS3 experiment, to observe its 
fragmentation and confim1 its structure. Keeping the same parameters as before, it 
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fragmented to give the main product [GicNAcr oxonium ion at m/z 204.52 and also the 
[Cholestadiene+l-lr product ion at m/z 369.75 (Figure 3.6). 
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Figure 3.6: Second-generation mass spectrometry analysis or quasi-MS3 of the ml z 572, product ion 
derived from the 8-(cholest.-5-en-3-~-y loxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-~-D­
galactopyranosyl-a-D-galactopyranoside, molecule "3". 
Use of Xo nammg fol lows the work presented by Domon and Costello6 1 
represented in Figure 3.7. 
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Figure 3.7: Probable fragmentations occurring for disaccharides61 
Elimination from the product [DGaiNAct oxonium ion, during the quasi-MS3, 
gave the product ions [DGaiNAc-H20t at m/z 186.51 and [DGaiNAc-H20_2.4Xot at m/z 
126.4 7 (Figure 3.6). This spectrum helped to confirm the structure of the [C-glycoside+ l-1 
-DGal] t- ion-species, which occurs due to an ion-molecule reaction occurring between the 
[DGaiNAct oxonium and the [Cholestadiene+Ht. The appearance of a second C-
glycoside ion-species derived from a disaccharide neoglycolipid derivative was not 
previously observed. 
The fact that the [C-glycoside+ H-DGalt ion-species was not observed in the 
second-generation tandem mass spectrometry analysis or quasi-MS3 of the l C-
glycoside+Ht ion-species, but was observed in the conventiona l scan and in the tandem 
mass spectrometry analysis of [M+Ht at mlz 884.52, suggests that the [C-glycoside+H-
DGalt ion-species might originate directly from the [M+ Ht and [M+ l-1-DGal]'. It might 
be formed due to consecutive reactions occurring at the same time. 
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3.4. 11-(Cholest-5-en-3-P-yloxy)-3,6,9-trioxaundecyl-a-L-fucopyranoside ( 4) 
Based on work previously done in thi s laborato ry,23 it was determined that the 
neoglycolipids that conta in a fucosyl residue of the carbohydrate moiety were not able to 
fo rm the [C-glycoside+Ht ion-species. In the novel series of free-neoglycoli pids, there 
was indeed a fucosyl compound , name ly 11 -(cho lest-5-en-3-~-y loxy)-3,6,9-
trioxaundecyl-a -L-fucopyranoside. Tandem mass spectrometry of this molecule revealed 
the basic constituent product ions arising from the protonated molecule [M+ H] f- io n at m/z 
709.0623 and no evidence of fo rmation of the C-glycoside ion-species around m/::: 576 
(Figure 3.8). 
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Figure 3.8: Tandem mass spectrum of the ll -(cholest-5-en-3-~-yloxy}-3,6,9-trioxaundecyl-a-L­
fucopyranoside (molecule "4") protonated molecule I M+H I+ at m/z 709.06 by ESI-QqTOF-MS/MS. 
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It hould be noted that the ample was dis olved in MeOH, and formic acid wa 
added to promote the fom1ation of the protonated molecule at m/::. 709.06 in the 
conventional ES I-QqTOF-MS. The presence of several fragment ions such as 
[Cholestadiene+I If at m/z 369.12, and fFucose-CI-IJOHt at m/z 133 .00 were also noted. 
It should be noted that it is pos ible for the neoglycolipid to fragment at the spacer end 
producing the fChole tadieneSpacer+H 11 ion at m/z 563.11 and the I FucoseSpacerJ 1 ion 
at m/z 340.95. As expected, no [C-glycoside+I-If ion-species formation was observed at 
mlz 516, confirming the original hypothe is of a similar fucosyl containing 
neoglycolipid.23 Thi confirms the original observation that an ncoglycolipid cholestcryl 
possessing a free-carbohydrate lacking the 2-deoxy-2-acetamido or 2-dcoxy-2-amino-
group at position C-2 , could not produce the [C-glycosidef ion-spccies.23 The following 
figure represent the ions obtained from the molecule after ionization (Scheme 3.3). 
47 
+ 
[M+Hr m/z 709.06 
[FucoseSpacerr m/z 340 95 
+H r 
[Cholestad lene+Hr m/z 369.12 
r [Fucose-CH30Hr m/z 133.00 
[CholestadieneSpacer+Hr mlz 563 11 
[Spacer+Hr m/z 194 99 
Scheme 3. 3: Ions resulting from the tandem mass spectrometry of the protonated molecule I 1-(cholest-5-en-3-P-yloxy)-3,6,9-trioxaundecyl-a-L-
fucopyranoside (molecule "4") jM+H(. 
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3.5. Discussion 
In the conventional ESI-MS of compounds 1 and 3, the fo rmation of the 
corresponding protonated molecules was always observed, as well as the expected 
fragment ions produced from the protonated molecules. In addition, the formation of the 
[C-glycoside+ Ht . . JOn-species, the respective roxoniumt IOn, and the 
[Cholestadiene+Ht ion were also observed. 
The [C-glycoside+Ht ion-species was as well observed in the CID-MS/MS 
analyses during low-energy collision dissociation in the collision cell of the tandem mass 
spectrometer. 
Its isolation by a quasi-MS3 allowed its structure to be verified. The formation of 
both individual product ions: the 1 ,2-oxazolinium ion and the cholesta-3,5-diene ion was 
noted and confirmed the structure of the [C-glycoside+Ht ion-species formed by an 
intramolecular ion-molecule complex reaction . This dual formation can be explained by 
the fact that during the CID-MS/MS process, two competitive mechanisms occur, as 
described in Chapter 1. 
Therefore for a short period of time, these product ions and neutral molecules arc 
all present in the collision cell as part of the complex transition state, which breaks down 
by an intramolecular mechanism to form the [C-glycoside+Ht ion-species . 
Molecular modeling based on thermodynamic parameters (proton affi ni ties) is 
normally used to determine which type of complexation can happen, prior to the CID-
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fragmentation. [n this case, such modeling between the I ,2-oxazolinium and the neutral 
cholesta-3,5-diene was not perfom1ed. However, even if theoretical thermodynamic 
calculations (such as the multiconfigurational self-consistent field theory, coupled cluster 
theory and two density-functional theory-based methods)62 were used, the results 
obtained compared to the theoretical calculations should conclude that the breakdown of 
the activated ion molecule complex break down by an internal ' intramechanism" with 
. I. . . f I I I 63 64 consecutive e 1mmat1on o t 1e spacer mo ecu e. · 
Nevertheless, it has been postulated that the sugar oxazolinium ion is 
thermodynamically favored for the protonation site64 over the cholestadiene. This 
oxazolinium ion can form a pseudo ionic bond with the neutral conjugated cholesta-3,5-
diene, which results in the complexation. [t should be further noted that the occurrence of 
such complexation has been identified using other samples and various mass 
spectrometers such as Cl-MS/MS,64 ES I-MS/MS,65·66 ion trap-MS/MS67 and triple 
quadrupole-MS/MS.65 
The formation of the [C-glycosidet ion-species appears to be dependent on the 
concentration of the sample, the declustering potential and the focusing potential. 
Previous research shows that the ion-molecule reaction can also be influenced by the 
temperature. 67 
In conclusion, it is tentatively presumed that the ion-molecule reaction can occur 
by intramolecular mechanism between the positively charged [I ,2-cyclic oxazolinium]' 
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and the neutral molecule of cholesta-3,5-diene as part of the activated ion-molecule 
complex. 
In this case study, it was interesting to note the formation of two types of related 
[C-glycoside+Ht ion-species for the disaccharide compound 8-(cholest-5-en-3-P-yloxy)-
3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-P-D-galactopyranosyl-a-D-galactopyranoside 
3. The disaccharide [C-glycoside+H] ion-species was formed, as expected, between the 
I ,2-oxazolinium ion and the neutral cho lesta-3 ,5-diene. It also showed a complex 
fragmentation, where some product ions have not been determined yet, but could re ult 
from direct elimination from the C-glycoside ion-species. In addition, the [C-
glycoside+H-DGal] ' ion-species was also formed by elimination of the non-reducing end 
galactopyranosyl moiety from the disaccharide g lycosyl portion of the protonated 
molecule [M+Ht. The formation of this [C-glycoside-DGai+Ht ion-species rationalized 
from an ion-molecule reaction between the rGal Act mono accharide I ,2-oxazolinium 
and the neutral cholesta-3 ,5-diene. The monosaccharide [Gal Act 1,2-oxazolinium ion 
is formed by c leavage of a P-D-galactopyranosyl residue from the disaccharide portion. 
Therefore, the CID-MS/MS of the protonated molecule 3 allows the structural 
elucidation of the disaccharide neoglycolipid into two different ions species uch as the 
[C-glycoside+Itf and the [C-glycoside-DGait (Scheme 3.4). 
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Scheme 3. 4: Representation of the two different JC-glycosidel+ ion-specie i sued from the 
prot on a ted molccu lc 8-( cholest-5-en-3-~-yloxy)-3,6-d ioxaoctyl-2-accta m ido-2-d coxy-3-0-~-0-
ga lactopy ra nosyl-a-0-ga lactopyra nos ide ( mo lccu lc" 3 " ). 
Note that the ions species [C-glycos ide+Ht and [C-glycosidc 11-DGal] 1 were 
produced from the disaccharide protonatcd molecule. However, the ion-specie [C-
glycos ide+ II-DGal] 1 was also formed from the quasi-MS3 of the I M+II-DGait ton. 
Finally, thi s discovery was new in the fi e ld o f neoglycolipid studie fo rming a potentia l 
C-glycoside ion-species. 
Previous work has shown that the fucose glycolipid cannot rearrange after 
fragmentation, to give a [C-g lycoside+ l It ion- pecies.23 Thi was pro en to be corr ct 
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for the ESI-QqTOF-MS and CID-QqTOF-MS/MS of the compound 11-(cholest-5-en-3-P-
y loxy )-3 ,6, 9-trioxaundecyl-a-L-fucopyranoside 4. 
In conclusion, the ESI-MS and MS/MS studies of the fucose glycol ipid 4 and the 
series of the mono- or disaccharides containing the 2-N-acetamido or 2-amino-2-deoxy 
sugars allowed the verification of the requirement of the N-acetyl group or the amino 
group portion of the analyzed glycolipid, to allow the reaction between the neutral 
cholesta-3,5-diene and the 1 ,2-cyclic-oxazolinium ion to produce an ion-species such as 
[C-glycoside+Ht. 
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Chapter 4: 2-Acetamido-2-deoxy-D-g/ycopyranosy/ per-0-acety/ated neoglycolipids 
A new series of per-0-acetylated compounds (Figure 2.3) containing the a-D-
glycopyranosyl and di accharide containing the GlcNAc residue wa used to confirm by 
ES I-QqToF-M /M analy es, that these per-0 -acetylated neoglycolipids did not form the 
[C-glycoside+ll] 1 ion-species during the fragmentation of the precursor protonated 
molecules obtained, as indicated earlier,5·23 and in Chapter 3. 
4.1. Mass spectrometric analyse of the 2-acetamido-2-deoxy-0 -glycopyranosyl 
per-0-acetylated neoglycolipids 
4.2. 8-(Cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-acetamido-4,6-di-0-acetyl-3-0-
(2,3,4,6-tetra -0-acety 1-P-0-ga Ia cto py ra no y 1)-2-d eoxy-a-0-ga I acto pyranose (5) 
4.2. 1. Qq-TOF analysis 
The full scan ES I-MS analysis of the molecule 5 gave the I M+llf ion at m/::. 
11 36.2500, the fragment [DGaiDGal Ac pacer] 1 ion at m/::. 768.3224, the disaccharide 
I Gall ~Gic Ac4l oxonium ion at mlz 6 18.3637, the [Chole tad iene+IIf ion at m/::. 
369.6991 and the monosaccharide [DGall~ oxonium ion at m/::. 33 1.4733. Additional 
eliminations from the [DGalt oxonium ion were observed at ml::. 169.4484 and ml::. 
150.4247. They were assigned as I DGai-2AcOH-CH2COf and [DGal Ac-H20 -
2AcOHt , respectively resulting from con ecutive losses of acetic acid and ketene 
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(Cl-bCO) molecules or by the losses of water and acetic acid. Such acetic acid and ketene 
losses were previously reported60 with carbohydrates present in lipid A obtained from a 
lipopolysaccharide. Interestingly, the monosaccharide oxonium ion [DGaiNAct derived 
from the dissacharide was noticed at mlz 288.4927, which suggests a few possibilities for 
the fragment ion at m/z 169.4484, which could also be a [DGaiNAc+H-2AcOH]' 
obtained from elimination of acetic acid. It appears that for the per-0-acety lated 
neoglycolipids, the elimination of the molecules of acetic acid and ketene more likely 
blocks the formation of the 1 ,2-cyclic oxonium ion (Figure 4.1), which in that case is not 
formed and hence fails to react with the cholestadiene. 
[M+Ht I 
1136.25 0 
... ~ <01 .•4 
11H-J•o ~HI,-JZ• IN .. n••ITJI'>,_, 1"'"•-.o M 7 to,.., 
, , ~~- ' ,,., ,., ,go ,~,. lL_. A ·-' . };;,' -- ·.~;- ' J .. ~ .. ~,!,. - I ,;, 
270.4828 
.,J [M+Na( 1158 1;~ 
Figure 4.1: Full scan spectrum of 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl 2-acetamido-4,6-di-0 -
acetyl-3-0-(2,3,4,6-tetra-0-acety 1-P-D-ga lactopy ra nosyl)-2-deoxy-a-D-ga lactopyra nose, molecule "5". 
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There was no ion observed at mlz 985.5999, whereas there would have been if a 
[C-glycoside+Ht ion-species had been present. 
4.2.2. CID-MS/MS analysis of the protonated molecule 
A CID-MS/MS of the [M+Hf precursor ion at mlz 1136.25 was performed, and 
indicated that the protonated molecule [M+Ht at m/z 1136.27 generates, as expected, the 
product ion [DGaiOGaiNAcSpacer+Ht at mlz 768.32, the [DGaiOGalNAct at m/::. 
618.36 and also the [Cholestadiene+Ht at m/z 369.69. The monosaccharide non-reducing 
end oxonium [DGal] at mlz 331.47 and the reducing end of the disaccharide [OGaiNAc]' 
at mlz 288.48 were also noticed (Figure 4.2). 
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Figure 4.2: CID-MS/MS of the protonated molecule 8-{cholest-5-en-3-~-yloxy)-3,6-dioxaocty l 2-acetamido-4,6-di-0-acetyl-3-0-(2,3,4,6-tetra-0-
acetyi-~-D-galactopyranosyl)-2-deoxy-u-D-galactopyranose IM+H( at mlz 1136.27, molecule "5" . 
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4.2.3. Cl D-MS/MS of the sugar-spacer and the sugar 
The 10-MS/MS of the ions [DGalDGaiNAcSpacer] 1 at m/z 768.32 and the 
[DGalDGalNAcf at m/z 618.36 were perfo rmed using second-generation product ion 
scans (data not shown). The product ion [DGaiNAc-H20f at m/:: 270.49, fo r both 
preselected analyzed ions could be obser ed. The [DGal Ac-H20-Ac011l '" product ion at 
m/z 210.47 and the [DGalNAc-2Ac01 [-J-120 1'" product ion at m/z 150.47 were also 
noticed during the quasi-M S3 of the ro GalDGalNAcf oxonium ion. It was previously 
found that product ions arising from consecutive or concerted los es of acetic acid and 
water, happened at the same time and in same region of reaction in a hybrid tandem rna s 
spectrometer.60 During the CID-MS/MS analysis of the [DGaiDGaiNAcl'" oxonium ion, 
elimination of the two product oxonium ions [DGalf and ro oaiNAc I' was observed. 
The CID-MS/MS analy e of the sugar moiety permitted us to obtain a precise fingerprint 
of molecule 5. In fact, it was observed, during the acquisition of the full scan that two 
possible ion could be i sued from both saccharides at mlz 169. This ion was also present 
during the CID-M /MS of [M+H( In addition, it was observed that the 0-acetylatcd 
groups protect the molecule and appeared to be diffi cult to break in one step. This 
phenomenon is applicable to the protonated molecule as well a fo r the carbohydrate 
moieties. Scheme 4.1 represents all the conclu ions derived from the results obtained 
during conventional, CID-MS/M analyses of the 8-(chol est-5-cn-3-~-yloxy)-3 ,6-
d i oxaocty 1-2-acetam ido-4,6-d i -0-acety 1-3 -0-(2,3 .4 ,6-tetra-0-acct y 1 -~-D-
galactopyranosyl)-2-deoxy-a-0 -galactopyranose (5) and CID-M /MS analyses of its 
product ions. 
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Scheme 4. I: Proposed fragmentation pathway of 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-acetamido-4,6-di-0-acetyi-3-0-(2 ,3 ,4,6-tetra-0-
acetyl-~-D-galactopyra nosy I)-2-deoxy-a-D-ga lactopyra nose, molecule "5". 
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4.3. Cholest-5-en-3-~-yl-2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-~-L-
glucopyranoside (6) 
4.3.1. QqTOF-MS analysis 
In the conventional full scan ESI-M S analysis, the presence of the sodiated 
molecule [M+Nat at m/z 738.5098 and also the presence of the protonated molecule 
[M+Ht at mlz 716.5520 was found, in addition to the fragment ion A 
[Cholestadiene+Ht at m/z 369.7110, and the B1 [LGicNAct, or [Oxoniumt ion at mlz 
330.4962, and its derivatives (Figure 4.3). 
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Figure 4.3: ESI-MS of the cholest-5-en-3-~-y l-2-acetamido-3,4,6-tri-0-acety l-2-deoxy-~-L­
glucopyranoside, molecule "6". 
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4.3.2. CID-MS/MS analysis of the protonated molecule 
The low-energy CID-QqToF-M /MS of the selected product ion [M+Hf at ml:: 
716.55 re ulted in the formation of the product ions: [Cholestadienc+ll t A at m/z 369.72. 
the [SugarOII] 1 8 (also called the [Oxonium+ H20t ion), at m/z 348.49; and the oxonium 
[L-GicNAct 8 1 at m/z 330.50. The 0-acetylatcd product oxonium ion fL-GicNAct 8, 
fragmented into the product ions l Oxonium-AcOHt 8 3 at mlz 270.5 1, [Oxonium-
2Ac01-1] 1 8 5 at mlz 2 10.49, or [Oxonium-3Ac011] ~ 8 7 at m/z 150.45 from the product ion 
fM+ Ht. By changing the collision energy from I 0 to 15 eV during the C ID-MS/MS of 
the protonated molecule [M+Ht, two new product ion could be detected, presumably 
that of [M+H-2AcOHt at mlz 596.60 and [Oxonium-CH2COt 82 at ml:: 288.5 1 (Figure 
4.4). As previously stated, raising the collision energy results in the formation of more 
product ions. 
61 
I 
348.49 
_.348 «:147 
B 716.55 
.... 
B 
Bs B3 B1 0'1 B4 B2 lll "": rl 
<:t 0 lll 
c::i rl 0 rl 
' 0 " Ll"l N r-. lll 
rl N 00 
00 
N 
288 soee 
. .. 5000<' 
0 .. 
wo 300 3<50 
""" 
""0 eoo e.50 
Figure 4.4: Tandem mass spectrometry analysis of the precursor ion IM+Hf at m/z 716.55, molecule "6". 
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4.3.3. CID-MS/MS of the ISugarOHt B 
The second-generation product ion scan (quasi-MS3) of the fu lly acetylated 
[SugarOHt B precursor oxonium ion at m/z 348.49 was performed with a CE of I 0 cY 
(Figure 4.5). 
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Figure 4.5: Second-generation tandem mass spectrometry of the !SugarOH r also called I L-
CicNAcOHr, molecule "6". 
The product ions issued from B were similar to the ones obtai ned during the 
conventional scan analysis and the C ID-MS/MS of the protonated molecule. The 
elimination of acid acetic and ketene molecules was observed and confirmed. Additional 
elimination was observed at m/z 168.47 assigned as a [LGicNAc-2AcOH-Cf-hCO ( B(,. 
The ion observed at m/z I 09.42 was not identified. 
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Scheme 4.2 represents a tentative representation of the fragmentation pathway of 
the protonated molecule [M+H( It focuses on the monosaccharide product ions. In fact, 
the protonated molecule breaks down into the [L-GlcNAcOH+ H] ' ion "B" at m/z 348.13 
and the [Cholestadiene+ Ht ion "A" at m/z 369.35. This [M+Hf ion is also able to 
fragment into the [L-GlcNAct oxonium ion " B1"at m/z 330.12. The data obtained from 
the second-generation tandem mass spectrometry analysis of B permitted the 
determination of the fingerprint of the sugar moiety of the per-0-acetylated neoglycolipid 
6. 
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Scheme 4. 2: Proposed fragmentation pathway for the molecule cholest-5-en-3-~-yl-2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-~-L-glucopyranoside, 
molecule "6". 
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4.4. Discuss ion 
T he analyses o f the molecules 5 and 6 permitted us to confirm prevtous 
research5·23 regarding per-0-acetylated neoglycolipid fragmentation. Consecutive or 
concerted e limina tion of acetic acid and ketene molecules prevents the possible 
production of an unprotected oxonium ion such as a deacetylated oxonium ion. It was 
found earlier that the oxonium ions a re extremely reactive and will prefe rent ia ll y 
e liminate molecules of acetic acid and ketene, by concerted mechani sms and by 
destabiliz ing the I ,2-cyclic oxazolinium ion. T herefo re, this oxazolinium ion docs not 
have the time to fom1 the cyclic reacti ve species that can react with the e lectro phil ic 
cho lesta-3,5-diene molecule fo und in the collision cel1."5 This "0-acetylated effect" likely 
prevents the fo rmation of the [C-glycoside+Ht ion-specie , as well as the overall 
reacti vity of the per-0-acetylated-sugar oxonium ions in the series o f per-0 -acety lated 
neoglycolipids conta ining the 0 -GicNAc and/or L-GicNAc residues. Needless to say, as 
the unprotected [GicNAct oxonium is not formed, it is not possible to have an ion-
mo lecule interaction with the cho lestad iene molecule, even w ith the presence of an 
acetamido on the C-2 of the carbo hydrate. In fact, as stated in Chapter 3, the presence of 
an amido or acetamido group is needed to permit an ion-molecule reaction between 
oxonium and cho lestadiene. However, the protection of the neoglycolipid by the 
acetylated group prevents this formation. 
During fragmentation of the free underivati zed and per-0-acetyla ted 
ncoglycolipids, the products ions such as cho lestadiene and other secondary product ions, 
derived from the diffe rent saccharide moieties, are similar. However, in the case of the 
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per-0-acetylated neoglycolipids, the mam difference remams m the number of 
elimination reactions producing acetic acid and ketene. During this work, it was found 
that these eliminations were favored over the formation of the I ,2-cyclic oxonium 
ton. Therefore, Scheme 4.3 presents the tentative rationale for the absence of the [C-
glycoside+Ht ion-species . 
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Scheme 4. 3: Lack of IC-glycoside+H 1+ formation from 0-acetylated neoglycolipid cholesteryl 
derivat.ives. 
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Chapter 5: The formation of a new C-glycoside ion-species from a new neoglycolipid 
series containing the 2-azido-2-deoxy-P-D-ga/actopyranosy / residue moiety 
A novel sen es of synthetic neoglycoconjugates, presented in Figure 2.4, 
conta ining the 2-azido-2-deoxy-~-D-glucopyranosy l uni t was subjected to e lectrospray 
ionization mass spectrometry analysis using the hybrid QqTOF-MS/MS instrument to 
investigate the formation of the co rresponding [C-glycoside+ I-I t ion-species inside the 
co llis ion cell during tandem mass spectrometry. 
The neoglycoconjugates of this novel sen es fo rmed a new type of jC-
glycoside+H-N2t ion-species. This latter product ion was presumed to be fo rmed from a 
result of three consecuti ve reactions which take place in the colli sion cell of the hybrid 
QqToF-MS/MS instrument. These internal consecutive reactions were c lassified as 
follows: i) the excision of the po lyethoxy cha in; ii ) the e limination of a 2 molecule from 
the oxonium ion, followed by ; iii) the fo rmation of the [C-glycoside+H-N2f ion-species 
by an intramolecular mechanism (Scheme 5.1 ). It is suggested that the internal 
e limination of the spacer and the N2 mo lecules, 111 addition to the intramolecular 
association between the sugar ion and the ne utral cholestadiene mo lecule, occurs in the 
gas-phase and w ithin the acti vated transition ion-molecule com plex. As previously 
mentioned, it is not possible to assess now with certainty whether the [C-glycoside+ II-
N2t ion-species is held by strong electrostatic forces or by a true covalent bond. 
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Scheme 5. l: Consecutive reactions occurring in the collision cell. 
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5.1. Mass spectrometric analyses 
5.2. Partially 0-acetylated galacto azido neoglycolipid 
5.2.1. 8-(Cholest-5-en-3-P-yloxy )-3,6-dioxaocty 1-3-0-(2,3,4,6-tetra-0-acety 1-P-
D-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-P-D-galactopyranoside (7) 
In the preceding analyses (Chapter 4), and also in previous rescarch,5·23 it was 
postulated that no [C-glycoside+ Ht ion-species could be obtained if the 0-acetylated 
group were present on the reduc ing end o f the carbohydrate moiety. Thus, it was of 
interest to try to use a disaccharide neoglycolipid fo rmed from a 2-azido-2-deoxy-~-D­
glucopyranosyl moiety, in which the non-reducing end group of the di saccharide was a 
per-acetylated galactopyranosyl derivative, and its reduci ng end contained a 4,6 cl i-O-
benzylidene non-participating group. This reasoning was chosen in order to show that the 
absence of the 0 -acetyl groups on the reducing end 2-azido-2-deoxy-~-D-glucopyranosy l 
moiety will not interfe re with the formation o fthe [C-glycoside+ I--I t ion-species. 
5.2.1.1. QqToF analysis 
The ESI-M S in Figures 5.1 and 5.2 show the expected sod iated molecule 
[M+Nat at m/z 1146.23 19 and the protonated [M+Ht molecule at mlz 11 24.3 180. It 
should be noted that the DP2 in these ESI-MS was increased to I 0 V, which enhanced the 
" in-nozzle" fragmentation o f the molecule 7. 
70 
I 
816.5091 
100 .. 811!1 ~OQ1 
. ,., 
oo.,. 
1146.2168 
.... 
1146 2H'B 
""'" 381.6680 
381 0080 
70" 
, .. 
1147 2201 
00 .. 
, .. 
~ 
:;::: 00 .. 
&i 
46% 
""'" 341 70 0 
, .. 
30 .. 
20 .. 
20 .. 
, .. 
10 .. 
313 orno 
1178 2163 
1096.3317 037 ~030 
I 
5Q 4684 
~41 7031 
8154 4617 1000 3317 
756.3631 
• 
500 0001 
... 
214421 171 !)4 10 
Figure 5.1: Full scan ESI-MS analysis of 8-(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyi-3-0-(2,3,4,6-tetra-0-acetyi-~-D-galactopyranosyl)-2-azido-4,6-
0-benzylidene-2-deoxy-p-D-galactopyranoside, molecule "7". DP IOOV FP 150V DP2 SV 
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Figure 5.2: Full scan ESI-MS analysis of 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyi-3-0-(2,3,4,6-tetra-0-acetyi-P-D-galactopyranosyl)-2-azido-4,6-
0-benzylidene-2-deoxy-p-D-galactopyranoside, molecule "7". DP 1 OOV FP ISOV DP2 1 OV 
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The presence of the product ion [M+J-1-N2t at m/z I 096.3317 could be detected. It 
has been shown in the literature that 2-azido-2-deoxy-pyranoside MALDI-ToF-MS 
analyses indicated that the azido group excised a molecule of N2, converting the azido 
group into a free- NH2 amino group.68 Other researchers have also noticed the loss of N2 
in different azido sugar compounds analyzed by electron ionization (EI), chemical 
ionization (CI), mass-analyzed ion kinetic energy (MIKE) and fast atom bombardment 
(F AB).69.70 
The ESI-MS also showed the formation of the [SugarS pacer] 1 fragment ion at m/:; 
756.3754 and the [Cholestadiene+Ht fragment ion at m/z 369.7430. Other fragment ions 
were also noted and were assigned to the non-reducing end of the disaccharide portion 
[DGalt oxonium moiety or [DGaiN3t oxonium reducing end of the disaccharide moiety. 
Finall y, a low intensity fragment was noticed at m/z 947.3147, which was assigned as the 
[C-glycoside-N2+Ht ion-species. The ES1-MS spectrum in Figure 5.2 is actually similar 
to that in Figure 5.1, the only difference being in the abundance of the ions, mainly due 
to the DP applied. 
5.2.1.2. Cl 0-MS/MS of the protonated molecule 
The ClD-tandem mass spectrum of the [M+Ht protonated molecule, is a source 
of quantitative information regarding the products ions obtained. The product ion scan of 
the protonated molecule 7 was divided in several sections, in order to explain the 
structure of all the product ions formed (Figure 5.3). 
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Figure 5.3: CID-MS/MS scan of the protonated molecule 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyi-3-
0-(2,3,4,6-tetra-0-acetyi-P-D-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-p-D-
galactopyranoside (molecule 7) at mlz 1124.32. 
The CID-MS/MS of the disaccharide 8-(cholest-5-en-3-P-yloxy)-3 ,6-dioxaoctyl-3-
0-(2,3,4,6-tetra-0-acetyl-P-D-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-p-
0-galactopyranoside 7 protonated molecule [M+Ht at mlz 1124.32 gave the l M+H-N2 1" 
product ion at m/z 1096.36 (Base peak). The other expected product ions were also 
detected such as the [SugarSpacer+Ht at m/z 756.38, the [Sugar-N2-AcOH-CI-bCO+ H] ' 
product ion at m/z 481.53, the [Cholestadiene+Ht product ion at m/z 369.74 and the 
[DGalt product oxonium ion at m/z 331.51. Finally, the formation of the product ion of 
the [P-0-Gal (1 ~3) B-D-GaiNAc-N2f C-glycoside at m/z 946.64 could also be detected. 
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The molecule 7 is characterized by three main components: i) the presence of the 
2-azido group on the 2-azido-2-deoxy-amino sugar; ii) the presence of the non-
participating 4,6-di-0-benzylidene group on the reducing end of the disaccharide portion ; 
and iii) the presence of the fully per-0-acetylated-0-galactopyranosyl non-reducing end 
of the di saccharide portion of the neoglycolipid. Therefore, it has been deemed that the 
presence of the 2-azido-2-deoxy group allows the formation of the [M+H- 2] molecule 
and these variations can also be the source of the novel C-glycoside ion-species assigned 
as a [C-glycoside+H-N2t ion species formed during the C ID-MS/ MS ana lysis of the 
protonated molecule [M+Ht . It has been established previously in the literature that the 
N2 elimination occurs by a spontaneous reaction.
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Figure 5.4: CIO-MS/MS spectrum region from mlz 990 to 1130 of the 8-(cholest-5-en-3-P-yloxy)-3,6-
d io xa octy 1-3-0-(2,3,4,6-tet ra-0-a cety 1-P-0-ga lac to py ran osy 1)-2-azid o-4,6-0-benzy I ide n e-2-d eox y-P-0-
galactopyranoside, molecule "7". 
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A new fragment was revealed at m/z 990.39 (Figure 5.4). A pos ible product ion 
was found for this ion, which can occur by loss of the 4,6-benzylidcne group in the form 
of a molecule of benzaldehyde (C6H5C IIO) followed by a loss of methanol from the 
protonated lM+H( 
Figure 5.5 shows the presence of the [C-glycoside+ ll- 2l ~ ion-specie at m/:: 
946.64 and the 1 SugarSpacer+Ht product ion at m/z 756.38. The characterized product 
ions formed by the loss of the non-reducing per-0-acetylated galactopyranosyl unit (331 
Da) at m/z 780.03 and m/z 766.60 were also noted . 
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Figure 5.5: C IO-M /M spectrum region from m/z 740 to 980 of the 8-(cholest-5-cn-3-P-yloxy)-3,6-
d ioxa octy 1-3-0 -(2,3,4,6-tet ra-0-a cety 1-P-D-ga Ia cto py ran osy 1)-2-azido-4,6-0-ben zy I id en c-2-d eox y-P-0 -
galactopyranosidc, molecule "7". 
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The product ion at m/z 780.02 could be obtai ned by loss of benzaldehyde, a 
methy l group, and the non-reducing galactopyranoside. The figure below represents its 
possible eventual structure (Figure 5.6). 
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Figure 5.6: Possible structure of the m/z 780.02 ion 
The following figure represents the possible structure of the product ion found at 
m/z 766.60 (Figure 5. 7). 
+ 
[M+H-~-OGalt rrlz 766.60 
Figure 5.7: Possible ion for mlz 766.60 
Figure 5.8 is based on the m/z region from 560 to 760 and reveals several product 
ions that appear to be deri ved from the [SugarSpacer+ I-rt ion. The [SugarSpacer+H-N2f 
product ion was assigned as m/z 728.39. The product ion at mlz 622.46 was assigned as 
the [DGaii ---+3DGlcNAc+ Ht , and the one at m/z 578.44 as a [DGai1 ---+3DGicNAc-N2f 
ton. 
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Figure 5.8: CID-MS/MS spectrum region from m/z 560 to 760 of the 8-(cholest-5-en-3-P-yloxy)-3,6-
dioxaoctyi-3-0-(2,3,4,6-tetra-O-acetyi-P-D-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-p-D-
galactopyranoside, molecule "7". 
Figure 5.9 represents the possible ions present in the spectrum in Figure 5.8. The 
product ion at m/z 742.50 was assigned as the [SugarSpacer-NH3t ion; the product ion at 
mlz 668.43 was assigned as the [SugarSpacer+H-N2-AcOHt ion. 
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Figure 5.9: Possible ion structures from the section mlz 560-760 
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The spectrum in Figure 5.10 shows the product ions from m/z 300 to 580. 
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Figure 5.10: CID-MS/MS spectrum from m/z 410 to 570 of the 8-(cholest-5-en-3-~-yloxy)-3,6-
dioxaoctyi-3-0-(2,3,4,6-tetra-0-acetyi-P-0-galactopyranosyl)-2-azido-4,6-0-benzylidcnc-2-dcoxy-p-O-
galactopyranosidc, molecule "7". 
Elimination of acid acetic and ketene was observed with the product ion at mlz 
481.53 assigned as the [Sugar+ H-N2-2AcOH-CH2COt ion. The product ion at m/::: 
569.49 was abundant in this section of the spectra (Figure 5.10); however, no plausible 
assignment could be made. Eliminat ion of the benzaldehyde molecule was observed at 
m/z 520.53 and assigned as the [Sugar+H-C6H5CHOt ion. Elimination o f a consecutive 
or concerted N2 molecule, in add ition to the per-0-acetylated groups and a molecule of 
acetic acid were observed at m/z 463.52 and mlz 421.53. The product ion at m/z 457.73 
was assigned as the [Sugar-C6 H5CH-AcOHt ion (Figure 5.11 ). 
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[Sugar-C6H5CH-AcOHt m/z 457.73 
[Sugar-N 2-2AcOH+Hr m/z 463.52 
Legend: 
Sugar= ~-D-Gai(1-3)-~-D-Gal 
Figure 5.11: Different possibilities for the m/z ions fo und from 300 to 570 
The m/z region from 240 to 400 (Figure 5.12), reveals less fragmentation. The 
main product [Cholestadiene+Ht ion at m/z 369.74 and the [DGalt product ion moiety 
at m/z 33 1.5 1 were found. Furthermore the product ion [DGaiN3-N2t was characterized 
at m/z 248.52. By looking at the different ions present in this region of the mass spectrum, 
the presence of the product ion [DGai-CH2COt at m/z 289.52 could be discerned . The 
presence of the product ion at mlz 276.53, which was characterized as the reducing end of 
the disaccharide moiety [DGaiN3t, was also observed. This provides evide nce that the 
product [DGaiN3-N2f ion formed at m/z 248 .52 indeed originates from the precursor ion 
[DGaiN3t at m/z 276.53. Finally, a low-intens ity product ion was observed at mlz 375.52, 
which was assigned as the [Oxonium disaccharide-2·4X 1-CH2COf ion, since its calculated 
value is eq ual to mlz 376.14. 
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Figure 5.12: CID-MS!MS spectrum region from m/z 240 to 400 of the 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyi-3-0-(2,3,4,6-tetra-O-acetyi-P-D-
galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-p-D-galactopyranoside, molecule "7". 
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The key product ions observed in the Figure 5.12 are represented in the fo llowing 
fi gure (Figure 5.13). 
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Figure 5.13: Tentative structure of the product ions from m./z 240 to 400 
Figure 5.14 appears to show the product ions deri ved from both the product 
oxonium and the 4 ,6-di-benzylidene-D-GalN3. In fact, their respective theoretical mlz are 
almost the same (m/z 230.07782 for the [DGai-AcOH-CH2CO+ Ht and m/z 230.08 12 for 
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Figure 5.14: CID-MS/MS spectrum region from mlz 100 to 240 of the 8-(cholest-5-en-3-P-yloxy)-3,6-
dioxaoctyi-3-0-(2,3,4,6-tetra-O-acetyi-P-D-galactopyranosyl)-2-azido-4,6-0-benzylidene-2-deoxy-p-D-
galactopyranoside, molecule "7". 
The product ion at m/z 230.53 occurs by losses of acetic acid followed by ketene 
from the [DGalt. The product ions at m/z 2 11.50, m/z 169.47 and m/z 161.52 are derived 
from the per-0-acetylated non-reducing galactopyranosyl moiety. The chemical structure 
of the 0-acetylated product ions derived from the fully acetylated carbohydrate DGal 
moiety are indicated in Figure 5.15. 
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Figure 5.15: Possible ions from IDGall+ 
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The product ion [DGaiN3t yie lds the product ion [DGaiN3+H-N2-I-bO-C6Hs-
CHO] ~ at m/z 133.5 1. lt should be noted that the product ion can be derived from the 4.6-
benzylidene group and is present at mlz I 09.43, which is mostly a [ 1-0-methyl-hex-1.3,5-
ene+I-It ion (Figure 5.16). 
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Figure 5.16: Possible ions from both oxonium and benzene ring 
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The second generation tandem mass spectrometric analysis of the carbohydrate 
moiety was not performed, but would have been of interest to determine the 
fragmentation pathway. 
The reconfirmation of the van ous gas-phase fragmentation routes of the I C-
glycoside+H-N2] 1 ion- pecies at m/z 946.64 was also performed. However, the product 
ion was impossible to isolate or to fragment. The protection o f the neoglyco lipids by the 
presence of the per-0-acetylated group could be a reason fo r thi s. 
5.2.2. 8-(Cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl 3-0-(2,3,4,6-tctra-0-acetyi-~-D­
galactopyranosyl)-2-azido-2-deoxy-a-D-galactopyranoside (8) 
5.2.2.1. QqToF analysis 
Molecule 8 differs from 7, as it does not have the 4,6-benzylidene group on the 
azido-0-galactosamine carbohydrate . The ES I-MS conventional scan analysis of 8 
demonstrated the presence of the sodiated molecule [M+Nat at mlz I 058.2729, and the 
protonated molecule [M+Ht was noticed in low abundance at m/z I 036.35 15. Evidence 
for the 2-azido influence was provided by the presence of [M+ I-1 - 2 1' at m/:: I 008.3860 
and the [C-glycoside+H-N2t ion-species at m/z 859.4893 (4.9296e-3%). The common 
diagnostic fragment ions derived from the protonated molecule were also observed: the 
[Cholestadiene+Ht fragment ion at m/z 369.7377, the [DGalf at m/z 33 1.5020 and its 
acetylated deri vatives, the fragment ion at mlz 169.4869 formed by the los of two acetic 
acid and one ketene molecules, and the fragment ion at mlz 15 1.5269 formed by the loss 
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three acetic acid molecules. The disaccharide was observed at m/z 519.3950 and with the 
polyethoxyspacer at m/z 668.4015 (data not shown). 
5.2.2.2. CID-MS/MS analyses of the protonated molecule 
In order to confirm the fragmentation pathway of molecule 8, and also to check 
the possibility of the creation "in situ" of the [C-glycoside+H]" and I C-glycoside+I-1-Nzt 
ions spec ies, low-collision energy tandem mass spectrometry analysis or the protonated 
molecule [M+Ht was performed (Figure 5.17). This indicated the presence of the 
expected product ions: [M+H-N2t at m/::: I 008.35, [SugarSpacer+Ht at m/z 668.41 and 
[Cholestadiene+Ht at m/z 369.74. Other product ions such as the rsugar- z.l f- at m/::: 
490.49, and two monosaccharides derived from the oxonium dissacharide structure 
lDGalt at m/z 331.49 were detected. The ion at m/z 151.53 was deduced to be formed 
from the loss of three acetic acid molecules from the [DGal]' . The [C-glycoside+Ht ion-
species at m/z 886 was not observed. 
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Figure 5.17: CIO-MS/MS spectrum of the protonated molecule 8-(cholest-5-en-3-~-y loxy)-3,6-
d ioxaocty I 3-0-(2,3,4,6-tetra-0-acetyl-~-D-ga lactopyra nosy 1)-2-azido-2-deoxy-a-D-ga lactopy ra nos ide 
(molecule "8") IM+HI+ at m/z 1036.36. 
It was also assumed that the [SugarSpacer+Ht product ion gave ri se to the ion at 
m/z 5 19.73, resulting from the excision of the spacer chain and was assigned as 
[Sugar+Ht (spectra not shown). 
Scheme 5.2 represents the eventual fragmentation pathway of molecule 8. 
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Scheme 5. 2: A possible fragmentation scheme obtained from the isolation of 8-( cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl 3-0-(2,3,4,6-tetra-0-acetyi-
P-D-galactopyranosyl)-2-azido-2-deoxy-a-D-galactopyranoside, molecule "8", protonated molecule IM+HI+ from CID-MSIMS of tnlz 1036.36 
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5.2.2.3. CID-MS/MS of the IM+H-N2( ion 
The product ion scan of [M+H-N2t was performed to look for the formation of 
the expected [Oxonium-N2t product ion and also the [C-glycoside+ H-N2] " ion-species. 
The precursor [M+H-N2t ion fragmented into three product ions; unfortunately these 
were not the one expected. In fact, the [Cholesta-3-enet product ion at m/z 371.46, and 
two other fragments were noted: a product ion at mlz 648.72, which was assigned as the 
[M+H-N2-DGai-CH30Ht ion, and another at m/z 6 17.40 which might be a [M+H-N2-
DGal-31-hOt ion. These ions are represented in Scheme 5.3. 
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Scheme 5. 3: Proposed fragmentation pathway derived from the second generation tandem mass 
spectrum of the I M+H-N2 l+ ion, molecule "8". 
Scheme 5.3 actually may hint to a remote deactivation from the non-reducing end 
group to the reducing end group, hence preventing the formation of the expected IC-
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glycoside+H-N2t ion-species and the fragmentation of this protonated disaccharide 
molecule. This demonstrates that there are three competing reactions: the losses of the 
acetyl groups from the per-0-acetylated D-galactose, losses of methanol, and the 
consecutive el imination of water from the 2-azido-2-deoxy-D-galactosami ne. 
5.2.2.4. CID-MS/MS of the fSugarSpacert ion 
The second-generation CID-MS/MS of the [SugarSpacert at m/z 668.57 was 
conducted to confirm the fragmentation routes of this product ion, and to attempt to 
observe the two constituent monosaccharides of the disaccharide. It was also anticipated 
that it would be possible to observe, what is now termed the "azido effect" (namely loss 
of a N2 molecule), on the fragmentation of this precursor ion. The fragmentation route fo r 
the [Amino-0-GaiSpacert ion at m/z 668.57 is represented in Scheme 5.4 and Figure 
5.18. 
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Scheme 5. 4: Proposed fragmentation pathway derived from the tandem mass spectrum of the 
ISugarSpacer( ion at mlz 668.57, molecule "8". 
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Figure 5.18: CI 0-MS/MS of the !SugarSpacer+H ( ion at mlz 668.57 issued from the molecule of 8-
(cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl 3-0-(2,3,4,6-tetra-0-acetyl-~-0-galactopyranosyl)-2-azido-2-
deoxy-a-0-galactopyranoside (molecule "8") 
This MS2 spectrum shown in Figure 5.18 demonstrates that the precursor 
disaccharide ion fragments into its two monomer product ions. The product ion at m/z 
elimination of nitrogen and methyl acetate molecules. The second product ion at m/z 
309.62 occurs by the loss of the per-acetylated galactopyranosyl non-reducing end from 
the precursor ion. 
93 
5.2.2.5. CID-MS/MS of the IC-glycoside+H-N2t ion-species 
The product ion scan of the [C-glycoside+H-N2t ion-species at mlz 858.45 was 
isolated from the CID-MS/MS spectrum of the protonated molecule 8, and the same 
conc lus ions were made as for compound 7. It was possible to isolate the [C-glycoside+II-
N2t io n-species, however, no fragments were obtained, which might be due to the pcr-0-
acetylated presence on the non-reducing end carbohydrate moiety. In fact, the per-0-
acetylated groups protect the neoglycolipid and inhibi t fragmentation. Another reason 
could be that the bond connecting the oxonium to the cholestadiene is a strong covalent 
bond. 
5.3. Discussion 
In the case of 8-(cho l est-5-en-3-~-yloxy)-3,6-dioxaocty i-3-0-(2J ,4,6-tetra-O­
acetyl-~ -D-galactopyranosyl )-2-azido-4,6-0-benzylidene-2-deoxy-~-D-galactopyranos ide 
7, it was evident that three structural substituents seemed to interfe re wi th the 
fragmentation routes: i) the presence of the 2-azido group. ii ) the partial 0-acetylation of 
the no n-reducing carbohydrate end moiety and iii ) the presence o f the 4,6-0-benzylidenc 
group on the azido 0 -galactosamine section. The presence of a possible [C-glycoside+II-
N2t ion-species was observed, and while it could be isolated, it could not be fragmented. 
Thi s ion was present during the conventional scan analysis and C ID-MS/MS analys is of 
the protonated molecule of the respective studied neoglycolipid 7 or 8. It is hypothesized 
that thi s phenomenon could be due to either the low concentration of the sample injected, 
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or to the presence of the 0-acetylated non-reducing carbohydrate moiety, which appears 
to protect the di saccharide molecule from further fragmentation. 
In the case of 8-(cholest-5-en-3 -~-yloxy)-3,6-d ioxaoctyi-3-0-(2 ,3,4,6-tetra-O­
acetyi-~-D-galactopyranosyl)-2-azido-2-deoxy-a-D-galactopyrano ide 8, it was noted 
that the ESI-QqTOF-MS was very similar to the one obtained for compound 7. The ESI-
MS afforded the protonated molecule [M+ I-It at mlz I 036, the sodiated molecul e 
[M+Nat at mlz 1058, the [M+H-N2t at m/z I 008, the [C-glycoside+H-N2t ion-species 
a t m/z 859, the [C holestadiene+Ht at m/z 369 and the [DGalt at mlz 331. The CID-
MS/MS of the protonated molecule 8 afforded the [M+H- 2f , the [SugarSpacer+Hf at 
mlz 668, the lCholestad ienet and the [DGalt among other ions. It became apparent that 
as predicted, compound 8 behaves exactly a compound 7 under the same ES I-M S and 
MS/MS conditions. Therefore three consecutive reactions govern the fragmentation of 
these compounds. The first one is the creation of the [C-glycoside+ H-N2t ion-species 
obtained from the reaction occurring between [Oxonium-N2 t and the neutral 
cholestadiene. which occurs 111 the activated transition ion-molecule complex by an 
intramolecular mechani sm, the second is the spontaneous elimination of a N2 molecule 
permitting the change of the 2-azido to a 2-amino group/ 3 while the last concerns the 
partial 0-acetylation of the non-reduc ing carbohydrate end moiety. 
It is interesting to note that Giorgi ' s group, at the Uni versity of Siena, Italy, 
analyzed these 2-azido partially per-0-acetylated molecules using an ion trap tandem 
mass spectrometer, and they observed that the [C-glycoside+H-N2J 1 ion-species was 
present during conventional scan analysis and also CID-MS/MS of the protonatcd 
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molecule. He showed that the abundant [C-glycoside+H-N2t ion-species fo rmed could 
not fragment by MS3 experiment in agreement with the ES I-QqToF-MS and MS/MS 
findings. In addition, Amster's group, at the Univers ity of Georgia, USA, conducted the 
same experiments with an FT-ICR-MS 11 instrument. In their case the [ -glycoside+ H-
N 2t ion-species was obtained in higher re lative abundance than the protonated molecule 
and they were able to isolate it, but it a lso did not fragment by an MS3 experiment. 
The [C-glycoside+H-N2t ion-species formation in situ in a cell colli sion can 
result from both the [M+Ht and [M+ H-N2f precursor ions. These findings a llowed the 
proposal of the possible fragmentation pathways of these two precursor ions, which both 
formed the [C-glycoside+H-N2t ion-species. The latter was proposed to be created (as 
described earlie r in Chapters 1 and 3) by an intramolecular mechanism. 
Even though, the [C-glycoside+ H-N2] ~ ion-species could not be fragmented, it is 
be lieved that the 2-deoxy-2-azido protonated molecule can spontaneously change into a 
protonated 2-deoxy-2-amino molecule, by loss of a molecule o f nitrogen. This new ly 
formed protonated amino molecule would then permit the formati on of the rc-
glycos ide+ H-N2t ion-species, which is formed by intramolecular reaction between the 
[Oxonium-N2f ion and the cholestadi ene molecule in the acti vated io n-molecule 
complex. 
Based on the ESI-MS, C ID-MS2 and MS3 scans and the proposed fragmentation 
pathways for 7 and 8 , it has been concluded that the benzylidene group could influence 
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the fragmentation route as well as the presence of the acetyl-group in the ~- or cx-D-
galactopyranosyl residue of the non-reducing end of the disaccharide group. 
Even though, the resistance to fragmentation of the [C-glycoside+ H-N2] ' IOn-
species cannot be fully explained in this chapter, the analyses carried out in Chapter 6 
with molecules 11 and 12 demonstrate that the [C-glycoside+ H-N2t ion-species can be 
isolated, if no 0-acetylated group is present on the saccharide moiety. 
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Chapter 6: Differentiation of anomers and constitutional isomers of some 
neoglycolipids 
Cholest-5-en-3-P-yl-2-acetamido-2-deoxy-P-0 -glucopyranosidc (9), and 8-
( cho lest-5-en-3 -P-y lox y )-3 ,6-d ioxaocty 1-2 -acetamide-2-deoxy-4-0-P-0 -
galactopyranosyl-P-0 -glucopyranoside ( 1 0) are neoglycolipid that have a lready been 
ana lyzed using E 1- IO-MS/M S.23 
The mo lecule 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-
0 -P-D-galactopyrano yl-a-0-galactopyrano ide 3, which was studied earlie r (Chapter 
3), is similar to 8-(cho lest-5-en-3-P-yloxy)-3,6-d ioxaoctyl-2-acctamido-2-deoxy-4-0-P-
0-galactopyranosyl-a-0-glucopyranoside (10), and the cholest-5-cn-3-P-yl-2-acetamido-
2-deoxy-P-L-glucopyranoside 2 is similar to cho lest-5-en-3-P-yl-2-acctamido-2-deoxy-B-
0 -glucopyranoside 9. The molecules 3 and 10 are constitutional i omcr , whereas 2 and 9 
are anomeric dia tereoisomers. Furthermore, two azido neoglycolipids numbered 11 (8-
(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0 -benzylidene-2-deoxy-a-0-
galactopyrano ide) and 12 (8-(cho lest-5-en-3-P-y loxy)-3,6-dioxaoctyl-2-azido-4,6-0-
benzy lidenc-2-dcoxy-P-D-galactopyranoside), which are both anome ric diastereoisomers 
were analyzed. 
In thi s chapter, some differences are noted in the low-energy C ID-MS/M, 
fragmentation pathways (presence of more diagnostic, hi gher intensi ty product ions) 
accord ing to the changes associated with the anomeric or isomeric effect and the 
diastereoisomeric difference, due to the change in the chemical tructures of some d ist inct 
neoglycolipid . 
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6.1. Differentiation of diastereoisomeric anomers 
6.1.1. 8-(Cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-benzylidene-2-
deoxy-a-0-galactopyranoside (1 1) vs 8-( cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-
azido-4,6-0-benzylidene-2-deoxy-P-D-galactopyranoside (12) 
Figure 6.1: Representation of the molecules II and 12 
It can be observed that the structures of 11 and 12 (Figure 6.1) have similarities to 
those of 7 and 8 as shown previously in Figure 2.4. The former are monosaccharides, 
while the latter are disaccharides. The common point is that both pairs of galactosamine-
spacer-cholesteryl compounds possessing a 2-deoxy-2-azido-group, containing a 4,6-0-
benzylidene group. Compounds 7 and 12 have ~-glycosidic linkages and compounds 8 
and 11 have a-glycosidic linkages to the cholesterol. 
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6.1.2. 8-(Cholest-5-en-3-~-y loxy )-3,6-d ioxaoctyl-2-azido-4,6-0-bcnzy lidene-2-
deoxy-a-D-galactopyranoside (11) 
The CID-tandem mass spectrum of the protonated molecule [M+l-1) ' at m/:: 
794.49 isolated from compound 11 gave a similar intensity for the molecular ion 
(73.64%) and the [M+I-I-N2t at mlz 766.54 (74.55%). According to the structure of 11 , 
the main expected product ions were the [Cholestadiene+Ht observed at mlz 369.68 and 
the azido carbohydrate moiety [DGalN3( at m/z 276.47, which created the product ion 
[DGaiN3-N2( at m/z 248.49 (Figure 6.2). 
I 
, .. 
[M+Hr m/z 794 
;::~ 
0 
HO~ 
N3 0 o o o 
\_/\._/\_/ 
co 
lD 
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lD 
m 
4 26.48 
+ 
766.54 
Figure 6.2: Tandem mass spectrum of the protonated molecule 1 M+H I+ of t.he compound 8-(cholest-5-
en -3-~-yloxy)-3,6-dioxaocty l-2-azido-4,6-0-benzylidene-2-deoxy-a-D-galactopyranoside, molecule 
" I I ". 
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The product ion formed by the polyethoxy spacer linked to the azido carbohydrate 
(1 00%) [a-D-GaiN3Spacer+Ht at m/z 426.48 was observed. The presence of the product 
ion at m/z 616.54 was noted and was assigned as a [C-glycoside+I-I-N2t ion-spec ies 
(Figure 6.3). The product ion at m/z 588.56 was assigned as [M-N2-2'4Xot (Figures 6.4-
6.5). 
Some other ions were also noticed in low abundance. The proposed fragmentation 
pathways of ions derived from the protonated molecule [M+Ht are presented in Figures 
6.4 to 6.5. 
Possibilities of [C-glycoside-N 2t 
CHMe 2 
[(C-glycoside)-NX m/z 616.54 
u + 
CHMe 2 
+H 
[(C-glycoside)+H-N 2t m/z 616 .54 
Figure 6.3: Possible structures for the product ion at tnlz 616 obtained during the C ID-MS/MS of the 
JM+H( protonated molecule, molecule "II". 
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Figure 6.4: Possible fragmentation pathway of the proton a ted molecule 8-(chole t-5-en-3-p-yloxy)-3,6-dioxaoctyl-2-azido-4 6-0-benzylidene-2-
deoxy-a-D-galactopyrano ide (molecule " 11 ", part I) 
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C H ]+ 16 5 H~ /"-. CH3 
0 / O - CH 
Q 2x 3 CHMe 2 
''x ~0  0 0 '~H 0 2 \_/ \___/ \___/ 
[M+Hr m/z 794.49 
[ o.rf0 J ~-c"""· ~0 0 0 0 ~ \__/\__/\__/ 
+ 
[(C-glycoside+HJ-NX m/z 616.54 
H ;::· 
0 / 0 
+ 
CHMe [ ;::· l 0 / 0 o· HO~ 
NH +H 
[(C-glycoside+H)-N2r mlz 616.54 
Figure 6.5: Possible fragmentation pathway of the protonated molecule 8-(cholest-5-en-3-p-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-benzylidene-2-
deoxy-a-D-galactopyranoside (molecule " II ", part 2) 
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Acquisition of the CID-M S/MS of the protonated molecule [M+Ht at m/z 794.49 
was also obtained by increasing the colli sion energy, to observe whether or not the [C-
glycoside+H-N2t ion-species at m/z 6 16.54 disappeared. In addition, the precursor ion 
scan of [M+H-N2t at m/z 766.54 was effected in order to determine if this ion-species 
arises directly from this ion. Two product ions at m/z 408.62 and mlz 436.40 were 
observed when the CE= I 0 eY. When the CE was increased to 15 eV, only the product ion 
at m/z 408.62 appeared. 
The product ion [C-glycoside+H-N2] at m/z 616.54 was a lso selected for a th ird-
generation product ion scan (quasi-MS4) . However, even by changing the coll ision 
parameters, the ion did not fragment. 
6.1.3. 8-(Cholest-5-en-3-~-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-benzylidenc-2-
dcoxy-~-D-galactopyranoside (12) 
The CID-MS/MS analyses of the protonated molecule of compounds 11 and 12 
were very similar. They both gave the protonated molecule [M+Ht at m/z 794, the 
[M+H-N2t at mlz 766, the cholestadiene at mlz 369, the [DGaiN3+Spacert at m/z 426 
andthe [DGaiN3t at m/z 276. Note that the ion corresponding to the formation of the [C-
glycoside+ H-N2t ion-species at m/z 644.55 was identi fied. 
104 
6.1.3. 1. CID-MS/MS of the protonated molecule 
The C IO-MS/MS spectrum of the protonated molecule [M+Ht at m/z 794.50 was 
acquired (Figure 6.6) and yielded the product ion [M+H-N2t at m/z 766.51 , due to the 
elimination of the N2 molecule caused by its instability.
74 The [SugarSpacer+H] ~ product 
ion was formed at m/z 426.47 (1 00%) and the [Cholestadiene+Ht product ion at m/z 
369.67. The fragmentation of the [0Ga!N3t oxonium at m/z 276.45 resulting from the 
cleavage of the disaccharide moiety was noted. The product ions at m/z 248.46 and at m/z 
239.50 were assigned respectively as the product ions [DGaiN3-N2t and [DGaiNJ-N2-
CH3t , and the [C-glycoside+H-N2t ion-species was observed at m/z 616.57. It is 
possible that the ion at m/z 588.59 is a derivative of the [C-glycoside+H-N2f ion-species 
formed by loss of a molecule of methanol ass igned as [C-glycoside+H-N2-MeOHt. 
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Figure 6.6: Tandem mass spectrum of the proton a ted molecule I M+H ( of the 8-( cholest -5-en-3-P-
y loxy)-3,6-d ioxaoctyl-2-azido-4,6-d i-0-benzy I idene-2-deox y-P-0-ga lactopy ra nos ide (molecule " 12") 
6.1.3.2. CID-MS/MS of the [M+H-N2 ( 
To determine if the product ion fM+ H-N2f posse smg the ~-anomeric 
configuration would fragment, this latter was selected for a quasi-M 3 scan (Figure 6.7). 
The second-generation product ion can revealed the pre encc of the [C-glycoside+l l-
N2t ion-specie at m/z 616.57, the [M- 2-0·2Xof ion at mh 558.64 and, finally, the [C-
glycoside-N2-C6H5CHO-C2H50H-
2AX0 I+ at m/z 436.45 according to the nomenclature of 
Domon and ostello6 1 (Figure 6.7 and Scheme 6.1). 
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Figure 6.7: CID-MS/MS of the ion 1 M+H-N1 ( with different collision energies 
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Scheme 6. I: Presumed product ions formed in the acquisition of quasi-M 3 of the ion I M+H-N2 ( 
6.1.3.3. CID-MS/MS of the IC-glycoside+H( ion-species 
The formed [C-glycoside+Hl ' product ion-species was observed at m/:::; 644.56 in 
the C ID-M /M of the protonated molecule and was also present in the conventional 
ES I-MS. Usually, it has been observed that the CID-MS/MS of the protonated molecule 
I M+ I-IJ ' affords the expected [C-glyco ide+! II ~ product ion and the product ions 
[Oxoniumf at m/z 248.09 and [Cholestadiene+ Ht at m/z 369.3 I . l lowcver, in this ca c, 
the product ions obta ined were different, due to the presence of the azido g roup, the 2-
deoxy-position of the aminosugar, and the 4,6-di-0-benzylidenc group attached to the 
non-reducing sugar moiety of the di saccharide g lycosyl portion of the neoglycol ipid. 
Obviously, it is reasonable to expect that the product ion can of the precursor [C-
glycoside+H] ion would fonn the product ions [Cholestadiene+ IIJ • at m/:::; 369.68 and 
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[DGal 3- 2f at m/z 248.45. The ClD-MS/MS of the [C-glycoside+ lll 1 ion-species is 
tentatively depicted in Scheme 6.2. 
[Gg~-+t-( mi61644 
Scheme 6. 2: Pos ibleiC-glycoside+H( fragmentation pathway derived from the second generation 
tandem mass spectrum 
Scheme 6.2 shows that in the second-generation tandem ma ·pectrum, the fC-
glycoside+ H t ion-species breaks down pontaneously to the product ion l C-
glycoside+H- 2] 
1
• In add ition, the selected precursor ion creates the diagno tic product 
ions [Cholestadiene+ II t and [DGaiN3- 2] 1• 
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6.1.3.4. CID-MS/MS of the IC-glycoside+H-N2 1+ ion-species 
The third-generation product ion scan (quasi-MS4) of the precursor 10n [ -
g lycoside+ H-N2f at m/z 616.57 wa accomplished more easily than the second-
generation ClD-M /MS of the precur or ion l C-glycoside+ H] ' at m/:: 644.57. In fact, 
on ly two product ions were observed: the roxonium- 2r ion at m/z 248.48 and the 
[Cholestadiene+Ht ion at m/z 369.67 (Figure 6.8). 
I 
NH 
[C-glycoside-N2+Hr 
co 
<:!; 
co 
'<t 
N 
1<WI"'"" 
• •r- --~ 
1:!10:1 AIU 
CHMe, 
616.57 
Figure 6.8: Third-generation tandem mass spectrometry of the IC-glycoside+H-N2 ( product ion at 
mlz 616.57, derived from the 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-benzylidene-2-
deoxy-p-0-galactopyranoside (molecule" 12") 
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6.1.4. Discussion 
In this study, the product ion scans of the protonated molecule rM+l It of 
compounds 1l and 12 are different and in both scans the [C-glycoside+ J-1- 2f IOn-
species could be observed. However, the molecule 12 also presented the [C-
glycoside+Ht ion- species. It is proposed that the a-anomeric configuration of compound 
11 may be the main reason for the lack of fragmentation of the [C-glycoside+ H-N2] 1 ion-
species. 
Table 6.1 shows the differences in abundance of the diagnostic product ions 
obtained from the two different tandem mass spectra of compounds 11 and 12 (Figures 
6.2 and 6.6). 
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Table 6. I: Comparison of the product ion relative intensities a nd m/z obtained during the acquisition 
of the Cm-MS/MS of both molecules II and 12 
I on 1 1 1 1 12 12 
Relative Relative 
intensity intensity 
m/z (%) m/z ('Yo) 
IM+ I-11+ 794.49 73.64 794.50 35.R3 
I M+I-1-Nzl+ 766.54 74.55 766.5 1 I R.40 
IC-glycoside+ H 1• 
- -
644.56 0.07 
IC-glycosidc+H-N21+ 6 16.54 5.45 6 16.57 2.79 
I M+I-I-Nz-uXol+ 588.56 2.73 588.59 0.58 
I M -Nz-0'2Xol + 558.64 0.9 1 558.62 0.26 
IDCaiN3Spacerl+ 426.48 100.00 426.47 I 00.00 
I DCaiN3Spacer+H-N21+ 398.48 2.73 398.47 0.45 
ICholcstad iene+H ( 369.68 24.55 369.67 3.82 
IDCaiN31+ 276.47 0.91 276.45 0.84 
I DCaiNJ-Nzl• 248.49 6.36 24R.46 1.03 
I DCa1NrC61-1sCI-I-2HzOI+ 151 .48 4.55 151.4 7 I. 7 1 
The relative abundance of the protonated molecule [M+Hl 1 was 73.64 % in the 
CID-MS/MS of the a.-anomeric structure, whereas the corresponding relative abundance 
for the P-anomer was equivalent to 35.83% (Table 6.1 ). 
The following graphic (Figure 6.9) represents a comparison of the abundances 
obtained from the fragmentation of the protonated molecules of both molecules 11 and 
12. 
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Figure 6.9: Comparison of the relative intensities of the product ions obtained during tandem mass 
spectrometry of the molecules 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-benzylidene-2-
deoxy-a-D-galactopyranoside (" 11 ") and 8-(cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-azido-4,6-0-
benzylidene-2-deoxy-p-D-galactopyranoside (" 12") 
It is well known that carbohydrate ~-anomers are thermodynamically less stable 
than the a-anomers. 72 A ~-anomer has an eclipsed configuration72 while the a.-anomer ha 
the less energetically favored staggered conformation. For example. the anomerization in 
solution (mutarotation) of a ~-anomer that forms the a-anomeric isomer was observed in 
the 1920's by Isbell. He also observed that a ~-0-glucopyranose reacts faster with 
bromine than the a-anomer.72 lt has been reported previously that the ~-anomeric 
glycosides fragmented more easily than the a-anomers during electron ionization high 
energy colli ion CID-MS/MS analyses. 70.73·74•75·76 It would be reasonable to expect that 
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this phenomenon would also apply for low energy CID-MS/MS analyses obtained using 
ESI ionization of the protonated molecule 11 having the a-configuration vis-a-vis the 
protonated molecule 12 having the 13-configuration. However, the ES I-QqToF-MS and 
C ID-QqTOF-MS/M analyses obtained did not support these observed features, as it was 
shown, that the a-anomer 11 formed more abundant fragment ions. 
Jt is interesting to note that a series of reactions were probably occurring in situ 
the collision cell like for the molecules 7 and 8 studied in Chapter 5. These reactions 
were: i) the excision of the spacer; ii) elimination of the 2 molecule from the protonated 
molecule; iii) formation of the [C-glycoside+ H( ion-species, as well as the formation of 
the [C-glycoside+H-N2t ion-species. The last ion gave rise to the expected [Oxonium-
N2t ion and the protonated molecule of cholesta-3 ,5-diene (Scheme 6.3). 
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[C-Giycoside+Hr 
[M+Hr 
+ 
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NH 
Spacer exci ion 
Lo s of 2 
[C-Giycoside+H-N2r 
+ 
CHME!;! 
[Cholestadiene+Hr 
Scheme 6. 3: Possible con ecutive reactions occurring in situ in the cell collision. 
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+ 
Figure 6.9 repre ents the relative abundance differences between both anomers. 
As seen in Table 6.1 , the a-anomer seems to create product ions having a higher relative 
abundance than those from the ~-anomer. This seems to contradict the findings obtained 
by electron ionization in conjunction with high-energy collision CID-MS/MS 
analyses.70·73.74·75·76 In Table 6.1 , which summarizes the fragmentation data, it was 
observed that the ~-anomer produced an additional product ion, presumably due to its 
relative instability compared to the protonated molecule of the a - anomer. ote that it 
has previously been reported in several articles that ~-structures give more fragment ions 
than the a-anomer.73·76 
In addition, the [C-glycoside+H-N2 r ion-species was found in both cases, and 
could be isolated and fragmented into the [Oxonium-N2t ion and the protonatcd 
molecule of ICholestadiene+Ht. This could not be accomplished with molecules 7 and 8, 
due to the protection afforded by the per-0-acetylated groups present on the carbohydrate 
moiety. 
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6.1 .5. Chole t-5-en-3-fl-yl-2-acetamido-2-deoxy-fl-L-glucopyranoside (2) vs 
cholest-5-en-3-fl-yl-2-acetamido-2-deoxy-fl-D-glucopyranosidc (9) 
2 
HO 
OH 
Figure 6.10: Representation of molecules 2 and 9 
The ES I-MS of compound 2 gave the expected fragment ions such as the 
protonated molecule [M+Ht at m/z 590, the fCholestadiene+l I I' ion at m/z 369, the 
[SugarOH] ion at m/z 222 and the [Oxonium] 1 ion a t m/z 204, a well as its deri vati ves 
(data not hown). The ESI-MS of compound 9 gave the same expected fragment ions as 
molecule 2 (data not shown). The product ion scans of the protonated molecules 2 and 9 
(Figure 6.10) are shown in Figures 6.11 and 6.12. 
117 
I 
ll"l ll"l 
~ ~ 
lD 00 
N ro 
,.,... rl rl 
t~ Cli'Ql. ll.OGII 
0
' ,oo no- 14"1 '~'~:;""'' 
204.08 
r-. 
0 
<ri 
00 
.-i 
,.., i';v J.SJ ~ /...._~..:t:MJt 
369.36 
--
ll"l 
<:t 
N 
r-. 
ll"l 
lD 
"<1: 
0 
"' ll"l 
-
Figure 6. I I: Low energy collision tandem mass spectrum of the protonated molecule of cholest-5-en-
3-P-yl-2-acetamido-2-deoxy-P-D-glucopyranoside 1 M+H 1+ (molecule "9") 
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Figure 6.12: Low energy collision tandem mass spectrum of the proton a ted molecule cholest-5-en-3-P-
yl-2-acetamido-2-deoxy-P-L-glucopyranoside I M+H I+ (molecule "2") 
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The abundances of the product ions obtained in both cases arc summarized in 
Table 6.2 . It should be noted that, for these two CID-MS/MS analyses, the fragmentation 
patterns are almost the same, even though the [Oxonium-21-h0-CH2CO I' product ion did 
not appear in the case of 2. Even though the relative abundance for the protonated 
molecule and the cholestadiene were higher for 9 than for 2 , it appeared that the precursor 
ion scan of the ~-L-configuration 9 produced a higher relative abundance for all the 
diagnostic product ions. Jn fact, the [GicNAc t product ion at m/z 204.08 was found to be 
the base peak for compound 9, and the different fragments derived from the [Oxonium! " 
gave almost twice the relative abundance than the value obtained with the structure D (9). 
Finally, the abundance of the [C-glycoside+Ht ion-species is - 1.15 % higher in the case 
of2 than 9. 
Table 6. 2: Relative intensities and mlz obtained for each product ions, when acquiring the tandem 
mass spectrometry of the protonated molecule I M+H r of the molecules 2 and 9 
Ion 2 2 9 9 
m/z Relative m/z Relative 
intensity(%) intensity(%) 
IM+H( 590.40 23 .58 590.46 43.74 
l C-glycoside+H ( 572.39 7.32 572.45 6.18 
ICholestadiene+H I+ 369.32 58.54 369.36 100.00 
ISugarOH( 222.08 55.28 222.09 38.32 
!Oxonium)+ 204.07 100.00 204.08 84.05 
[Oxonium-H2or 186.06 4.88 186.07 2. 14 
I Oxonium-2H20 I+ 168.05 3.25 168.07 1.60 
10xonium-2H20-COI+ 138.04 3.25 138.05 1.76 
[ Oxonium-2H20-CH2CO ( - - 126.05 1.37 
Jt shou ld be noted that the 0-Giycoside 2 has the ~-L-configuration and is 
levorotatory, while the 0-glycoside 9 has the ~-0-configuration and is dextrorotatory. It 
is interesting, in this case, to observe that the s lightly different diastereoisomeric 
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conformation tn space can influence the fragmentation pathways and the relati c 
abundances of the product ions obtained. Therefore, it is postulated that the reason for 
obtaining different re lative abundances may be due to the fact that the ~-L- and ~-0-
anomers are diastereoisomers (not mirror images). While the percentage abundance is 
double for the protonated molecule rM+Ht and for the [Cholestadiene+ll ] I in the case of 
the P-D-configuration, the abundance was higher for the other product ions obtained wi th 
the ~-L-configuration . Those differences are represented in the fo llowing chart (Figure 
6.13). 
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Figure 6. 13: Comparison of the relative abundances of the product ions obtained for diastereoisomers 
2 and 9 
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In summary, the formation of the [C-glycoside+Ht ion-species was obtained in 
situ in the collision cell for both diastereoisomers 2 and 9 and the relative abundance for 
this product ion was identical. 
6.2. Differentiation of constitutional isomers 
6.2.1. 8-(Cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-acetamido-2-deoxy-3-0-P-D-
galactopyranosyl-a-D-galactopyranoside (3) vs 8-( cholest-5-en-3-P-yloxy)-3,6-
dioxaoctyl-2-acetamido-2-deoxy-4-0-P-D-galactopyranosyl-P-D-glucopyranoside 
(1 0) 
teo O~OHO 
HO~o 
OH NHAc 
0 0 0 0 
\_)\_/\_) 
0~0 OH HO~o~O r\f\1\ 
OH HO~o o o o 10 
NHAc 
Figure 6.14: Representation of the molecules 3 and 10 
The ESI-MS of compound 3 gave the expected fragment ions such as the 
protonated molecule [M+Ht at m/z 884, the [M+H-DGal( at m/z 722, the 
[Cholestadiene+Ht at m/z 369, the [Sugart at m/z 516 and the [Oxoniumt at m/z 204. 
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T he ESI-MS of compound 10 revealed the same expected fragment ions as ob erved for 
molecule 3 . In order to compare compound 3 with compound 10 (Figure 6. 15), it was 
decided to inject compound 3 once more, this time using the same parameters used in a 
previously publi shed work .23 The a im of thi s comparison was to see if, with those 
paramete rs, it was possible to obtain the product ions [C-glycoside+ l-l f and [C-glycoside-
DGalt, and also to observe any di versity in abundances due to the conventional 
isome rism o f both structures. In fact, the saccharide of molecule 3 is connected by a P-
t ~3 0-glycosidic link, whereas the saccharide of molecule 10 is connected by a P-1 ~4 
0-glycosidic link. Moreover, the reducing end group of the di saccharide is a ~-D­
glucosaminyl unit in 10, whereas it is an a-D-galactosaminyl re idue in 3. However, the 
structure of the glucosamine a nd galactosamine are s imilar and should not interfere with 
the fragmentation. The comparison wa based on the tandem mass spectrum of the 
protonated molecule only (Figures 6.15 and 6.16). 
122 
I 
L/) 
q 
00 
,. r<"l 
..-< 
, __ 
N 00 
0 q 
oci g 
'~··"-~ 
o ... ,oo - - t. .~ - .I .~. 
366.14 
·- -...---.. ... , ... .- ,..... 
Figure 6.15: CID-M /MS of the protonated molecule 8-( cholest-5-en-3-P-yloxy)-3,6-dioxaoctyl-2-
acetamido-2-deoxy-4-0 -P-0 -galactopyranosyl-13-0 -glucopyranoside I M+H I+ (molecu le " I 0") 
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Figure 6.16: C ID-MS/MS of the proton a ted molecule 8-(cholest-5-en-3-p-yloxy)-3,6-dioxaoctyl-2-
acetamido-2-deoxy-3-0-P-0-galactopyranosyl-a-0-glucopyranoside I M+H (, molecule 3. 
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Table 6.3 highlights the results obta ined from the low energy colli ion tandem 
mass spectrometry analyses of the protonated molecule [M+Ht for both molecules 3 and 
10. The form ation of the [GicNAc( oxonium product ion has been observed for both 
molecules to ha e the same relative abundance ( 100%). The [ ugarSpacer]' product ion 
appeared al o to be identical in both ca e and the relative abundances were equal to .., .05 
% in 3 and 3.09% in 10. These were the only imilarities seen. Note that the a bundance of 
the protonated molecule 3 was very low (3.29%) when compared to molecule 10, which 
was greater by a factor of 8. In addition, it was observed that 3 gave more information 
regarding the structure and fragmentation o f the [DGal( I- 3)DGaiN3t disaccharide. ror 
example, the [Oxonium-HzOt product ion at m/z 186.06 and the f xonium-1120 -2.4Xol1 
product ion at m/z 126.04 fom1ed by a 2•4X0 cleavage were observed.61 Moreover, the 
lCholestadiene+Hf product ion at m/z 369.3 1 was not detected in the case of 10. The 
[Oxonium-2HzOt product ion at ml= 168.05 was only seen in 10. Fina lly the f -
glycoside+H] 1 ion-species was observed in both cases, with different abundances: the 
percentage abundance of this complex in 3 was higher, than in 10. However, 10 did not 
g ive the [C-glycoside-DGalt ion-species actually derived from e ither precursor ions 
[M+ H] or the l M+ H-DGal( There fore, it is hypothesized that the disaccharide 
protonated mo lecule 10 is less prone to fragmentation due to the pre ence and stabil ity of 
its ~- 1 -4 linkage, vis-a-vis the ga -phase fragmentation than the pro tonated molecule 3, 
which has a ~-1-3 linkage. Furthermore, no second C-glycoside ion-species or other 
product ions een with 3 were observed with 10. 
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Table 6. 3: Product ions mlz and relative intensities obtained from the scans of the protonated 
molecules 3 and I 0 by low collision energy tandem mass spectrometric analyses 
I on CID- CID-MS/MS CIO-MS/MS CIO-MS/MS 
MS/MS of of3 of tO ofJO 
3 Relative Relative 
abundance abundance 
m/z (%) m/z (%) 
[M+H( 884.54 3.29 884.58 26.64 
IC-glycoside+H I+ 734.45 1.64 734.56 0.77 
IM+H-DGal( 722.5 1 5.63 722.53 0.39 
I C-glycoside-DGall+ 572.39 1.4 1 - -
[SugarSpacer( 5 16.19 3.05 5 16. 16 3.09 
[ Cholestadiene+H ( 369.32 0.23 - -
[Sugar( 366. 13 100.00 366. 14 100.00 
I OxoniumSpacerl+ 354. 16 8.69 354. 18 0.39 
[Oxonium( 204.07 23.7 1 204.08 1.54 
[Oxonium-H20( 186.06 1.64 - -
10xonium-2H201+ - - 168.02 0.77 
I Oxonium-H20-2'4X0 [+ 126.04 1.64 - -
To conclude, there are several questions that still need to be answered concerning 
these CID-MS/MS analyses. Interestingly, second-generation C ID-MS/MS or quasi-MS3 
product ion scans of the [C-glycoside+Ht ion-species or l C-glycoside-DGalt at m/z 
734.45 and m/z 572.39, respectively, did not produce any product ions. As observed in 
Chapter 3, the [C-glycoside+Ht and [C-glycoside-DGalf ion-species were able to be 
gas-phase isolated and fragmented. Hence, it is possible that this was due to the change of 
the chemical structures of the mo lecules, or perhaps to the use of ideal gas declu tering 
and focusing voltage paran1eters, which need to be different for the di ffe rent 
neoglycoconjugates. In addi tion, the fully ~-anomer 10 produced less abundant product 
ions compared to the partiall y-~-anomer 3 (Figure 6.17). T hi confirms the postulation 
that before making a theoretical prediction, the analyses of the gas-phase fragmentations 
have to be done. 
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Comparison of the relative abundances of the 
product ions obtained for anomeric 
constitutional isomers 3 and 10 
Figure 6.1 7: Compa rison of the rela tive abundances of the prod uct ions obtai ned for a nomer ic 
constit ut iona l isomers 3 a nd 10 
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Chapter 7: Simple neoglycolipid containing the 2-deoxy-2-N-acety/ or 2-deoxy-2-
amino-glucosaminy/ residues 
This ection assesses the fragmentation pathway of the simple neoglycolipid 
during ESI-QqToF-M analysis. As the samples did not pos cs any chole tcryl moiety 
(Figure 7.1 ), no C-glycoside ion-species was anticipated to be formed . In fact, the 
fragmentation of the neoglycolipids containing the [GicNAc] ' portion was of more 
interest, in order to see if the gas-phase fragmentation would be affected by the presence 
of the 2-deoxy-2- -acetyl group on the amino sugar with respect to a free-2-amino-2-
deoxy-glucosaminyl glycolipid . 
13 
o~o~o~ / c 12H2s 
NHAc o 
~--~~.--0-C8H 17 
NHAc 
l.t 
Figure 7.1 : Representation of the molecules 13, 14 and IS 
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7 .1. Ethoxy-12-2-ethoxy 1-dodecanoxyi-2-N-acetyl-2-deoxy-p-glucopyranoside 
(13) 
A compari son between the ESI-MS conventional full scan and the C ID-MS/MS 
was attempted. It was observed that the conventional ESI-MS of molecule 13 was similar 
to that of the product ion scan of the protonated molecule [M+Ht at mlz 522.3646 
(Figure 7.2). 
I 544.3344 
204.0841 
522.3646 
,...., N 
l/1 00 
l/1 r--
0 0 
00 u:) 
126.0541 m ~ 12e~4 1_nH~:)I 1M 078? 
0~ •• - ~ •••••• - • _ L L . .----1.-..L...,. 
'\() 100 HIO XI(! 
Figure 7.2: Conventional scan of the ethoxy-12-2-ethoxy l-dodecanoxyi-2-N-acetyl-2-deoxy-P-
glucopyranoside, molecule " 13" . 
Hence, the CID-tandem mass spectrum of the protonated molecule [M+ Hf was 
recorded, to determine if the product ions were formed from the [GicNAct moiety 
(Table 7.1, Figure 7.3). 
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Table 7. I: Data obtained from the full conventiona l can a nd the C IO-MS/MS-QqToF ana lyses of the 
protonated molecule of 1-ethoxy-12-2-ethoxy l-dodecanoxyi-2-N-acetyl-2-deoxy-P- glucopyranoside 
( 13). 
I on ESI-MS CID-MS/MS 
m/z 522.36 
m/z 
[M+Nat 544.3344 -
JM+Ht 522.3646 522.61 
!Polyethoxy chain+AIIyl Chain +HI+ - 3 19.65 
IOxoniumf 204.084 1 204.48 
lOxonium-H20 ( 186.0782 186.47 
1 Oxonium-2 H20 ( - 168.45 
10xonium-2CHJOHt - 144.45 
I O xonium-2H20-CH30H t 138.055 1 138.44 
I O xonium-CH2C0-2 H20 ( 126.054 1 126.43 
The ES1-MS and CID-MS/MS shared some common fragment ions, however, the 
CIO-MS/MS contained more elimination product ions obtained by losses of molecules of 
water from the [GicNAct oxonium. The product ions were [Oxonium-2H20f at m/::: 
168.45, [Oxonium-2CH30Ht at mlz 144.45 and [Polyethoxy chain+AIIyl Chain+H] was 
observed at m/z 319.65. 
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Figure 7.3: Tandem mass spectrometry of the protonated molecule IM+H( of ethoxy-12-2-ethoxy]-dodecanoxyi-2-N-acetyl-2-deoxy-P-
glucopyranoside at m/z 522.61, molecule "13" . 
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Figure 7.4: Quasi-MS3 of mlz 204.48. 
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Second-generation quasi-MS3 analysis was performed on the [GicNAct oxonium 
at m/z 204.48. This precursor ion generated the product ions at m/z 185.48, 168.46, 
138.44 and 126.43, which are assigned in Table 7.1. It was observed that the product ion 
at mlz 126.43 was able to eliminate ammonia to produce the ion at m/z 84.39 (Figures 7.4 
and Scheme 7.1). Scheme 7.1 represents the proposed fragmentation pathway of the 
protonated molecule [13+1-1( 
[~~~~:-fur 
j0u1urj' 111=3);1.48 
~ r Oi 1 \ ~~Ac 
j0o1unl ~q' 11l= 1&>.47 
r~J JCkmm21 ~oa ~o q'111= 138.44 
j0u1Lm21 ~q'11l= 168.45 
Scheme 7. I: Proposed fragmentation pathway of the ethoxy-12-2-ethoxy 1-dodecanoxyi-2-N-acetyl-2-
deoxy-p-glucoiJYranoside, molecule" 13". 
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7.2. Octanoxyi-2-N-acetyl-2-deoxy-Jl-D-glucopyranoside (14) 
The full conventional ESJ-M S ana lysis gave the sod iated molecule [M+Nat at 
mlz 356. 1258, the protonated molecule [M+Ht at mlz 334. 1471 , and the lOxoniumf ion 
at m/z 204.0866. 
I 
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Figure 7.5: ESI-MS of the octanoxy i-2-N-acety l-2-deoxy-~-D-glucopyranoside, molecule" 14". 
The [Oxoniumt ion formed a series of secondary fragment ions resulting from the 
e limination of water molecules (Figure 7.5). 
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Figure 7.6: Low collision energy tandem mass spectrum of the precursor ion jM+Hl+ at m/z 334.57, molecule "14". 
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The CID-MS/MS of the protonated molecule 14 afforded the product [GicNAcf 
oxonium ion at m/z 204, and the series of secondary product ions resulting from 
elimination of water molecules (Figure 7.6 and Scheme 7.2). 
[ 
OH l HO "\_ ::,_ CZ~ HO~
NHAc 
I xon•umr m/z20 4 47 
[H~o6 o-c,H,]+ 
NHAc +H 
/ [M +H)" mlz 334.57 
[ 
OH l HO~
NHAc 
[ xon1um-H20]' m/z 186 46 [~] [ H ,c~ a· ] HOX-~~ 
NHAc 
[Oxon•um-2H 20)' mlz 166 44 
(Oxonium -2C H30Hr mlz 144 45 
[Oxon1um-C H 2CO]' m/z 162 46 
[ 
H
2
C l HO~
NH 2 
[= o· ] ~
{Oxon.um-3H10]' m/z 138 43 
Scheme 7. 2: Proposed fragmentation pathway for the octanoxyi-2-N-acety l-2-deoxy-~-D­
glucopyranoside (molecule" 14"). 
In summary, it was observed that the CID-MS/MS fragmentation pathway was 
governed by the polar carbohydrate moiety (Table 7.2). 
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Table 7. 2: Data obtained from the full conventional scan and the Cl 0 -MS/M -QqToF a nalyses of the 
protonated molecule octanoxyi-2-N-acetyl-2-deoxy-ll-D-glucopyranoside (14). 
I on ESI-MS CID-MS/MS 
m/z 334. 15 
m/::: 
(M+Nat 356.1258 -
(M+Ht 334.1 471 334.58 
(Oxoniumt 204.0642 204.47 
(Oxonium-H20t 186.0518 186.46 
(Oxonium-2H20t 168.0272 168.44 
(Oxonium-2CH30Hl+ - 144.45 
(Oxonium-2H20-CH30H I+ 137.9950 138.43 
I Oxonium-CH2C0-2H20 ( - 126.42 
7.3. Undecyloxyl-2-amino-2-deoxy-P-D-glucopyranoside (15) 
The conventional ESI-MS scan of 15, afforded the major ions I M+Naf at m/z 
356.577 1 and [M+ll] 1 at m/z 334.6066. The [Gic H2t was al o observed at m/::: 
162.466 1, and its elimination product [GleN I b-H20t formed by loss of water at ml::: 
144.4534 (Figure 7.7). The protonated dimer ions [2M+ IIf and 12M+ at at ml::: 
667.5049 and 689.4975, respectively, were also observed. 
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Figure 7.7: Full ESI-MS scan of the undecyloxyl-2-amino-2-deoxy-~-D-glucopyranosidc (molecule 
"15"). 
Low energy-CID-QqTOF-MS/MS of the protonated dimer [2M+I-I f at m/z 667.6 1 
afforded the formation of the protonated molecule [M+I-It at m/z 334.6 1 and the 
[GicNI-I2t at m/z 162.47 (Figure 7.8). 
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Figure 7.8: Tandem mass spectrum of the dimer protonated molecule 12M+H I+ at m/z 667.61 
The CID-M /MS analysis of the protonated molecule [M+III ' was also perform d 
(Figure 7.9), and gave the expected product ions, [Gic 1-12]" oxonium at m/z I 62.47, the 
rolcNI-12-1-hO I+ ion at m/z 144.45 and the rolcNI-12-21-120]" ion at m/z I 26.44. Finall y, the 
product ion I M+l-1-1-120]", resulting from loss of water from the precursor [M+H I' 
protonated molecule, was observed at m/z 317.59. The product ion at mlz 299.59 wa also 
formed resulting from the loss of two molecules of water, from the protonated molecule 
[M+H-21 hO J' ion (Table 7.3). 
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Figure 7.9: ClD-MS/MS of the precursor ion I M+H (at m/z 334.61 of the undecy loxyl-2-amino-2-deoxy-~-D-glucopyranoside (molecule" 15"). 
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Table 7. 3: Data from full scan and Cl 0-M /MS a nalysis of the undecyloxyl-2-amino-2-deoxy-P-D-
glucopyranoside, molecu le " IS" . 
I on ESI-MS CID-MS/MS C ID-
m/z 667.61 MS/MS 
m/z 334.61 
mlz 
[2M+Hf 667.5049 667.6 1 -
[M+Nat 356.2337 - -
[M+Hf 334.25 13 334.6 1 334.6 1 
[M+H-1-hOt - - 3 17.59 
fOxoniumt 162.0706 162.47 162.47 
I Oxonium-H20f 144.0622 - 144.45 
I Oxonium-2II20t - - 126.44 
Scheme 7.3 shows the propo ed fragmentation pathway of the protonated 
molecule 15. 
r"~o~ o-o,J l NH2 +HJ 
[M+H]" m/z 334 61 
rHO ~ O-o,"» r l NH2 +H J 
[M+H-Hp]" mlz 317.59 
HO ' O 
[ 
OH r HO~ 0 c,:~ rH0~1 l NH2 J 
[Oxonium-H20]" m/z 144 45 [M+H-NH:J• mlz 317 59 
[Oxonium]" m/z 162.47 
[Oxon,um-2H2or m/z 127.41 
Scheme 7. 3: Proposal fragmentation pathway of the undecyloxyl-2-amino-2-deoxy-P-D-
gl ucopyranoside (molecule "15"). 
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7.4. Discussion 
The purpose of this chapter was to detect any difference in the fragmentation of 
the carbohydrate moiety, compa red to the fragmentation of the carbohydrates in the 
previous neoglycolipid (1-12). 
The fragmentation pathway o f the protonated molecules 13, 14 and 15 were 
similar. The difference between these three glyco lipids was the presence o f a n acetyl 
group linked to the N H-group loca ted on C-2 for molecules 13 and 14. The fragmentation 
of the e molecules provided the expected fragments such as fGlcNAc-1-hOf, [Gic Ac-
2H20 ] ' , l Glc Ac-2H20-CH30Ht and (GicNAc-2CH30 H] ' . The excision of the 
po lyethoxychain linked to the allylcha in wa only observed for the mo lecule 13, since 
molecules 14 and 15 did not contain this feature. It is interesting to note the change from 
an aminoacetyl molecule to an aminomolecule by the presence of the I Glc Ac-C II2C0-
2H20 l' ion for both molecules. T he fact that the acetyl was able to be fragmented from 
theN-acetyl group is new compared to the molecules 1-12. 
The fragmentation of the aminoglucose g lycolipid 15 is related to the fragments 
obta ined from molecules 13 and 14, which lost an acetyl group. The expected fragment 
ions such as [Gic Ac-1-b Ot and [GicNAc-21120f were observed . 
It wa of interest to note than no rearrangement occurred between the 
carbohydrate and the a ll ylehain . 
In the MALDI-ToF-MS, these simple neoglycolipid moie ties were not observed. 
This was expected, as the fragment ions of the matrix interfered with detection of the 
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expected glyco yl ions. The matrices used for the MALDI-Tof technique were CI I A 
and OHB. Grant and Helleur77 observed that the addition of a surfactant on the matrix can 
allow cleaner detection of the analytes. llowever, this technique i not applicable in every 
case and is time consuming. ESI-QqTOF-M and ESI-QqTOF-MS/M analy es were 
proven to be efficient for the structural characterization ofneoglycoli pids 13, 14 and 15. 
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Conclusion 
A new series of free-neoglycolipid cho lesteryl derivati ves was stud ied in Chapter 
3. T he results obtained confi rmed the fragmentation pathway of each neoglycol ipid, 
which is necessary for future the rapeutic treatment of HI V or cancer. It a lso confirmed 
the formation the formation of a C-g lyco ide ion-species by an intramolecular mechani m 
occurring in the activated ion-molecule complex, in both conventional and C ID-M S/MS 
analyses, as indicated in previous research.5·23 ew info rmation was noticed regarding the 
fragmentation of the -glycoside ion-species. In fact, its fragmentation can be complex, 
depending on the parameters used. It was a lso noticed for the fi rst time that a 
neoglycolipid containing a disaccharide could produce two diffe rent C-glycoside ton 
species. The first C-glycoside ion-species was not proven to be a parent of the I C-
glycosidc-DGait using of ESI-QqToF-MS/M . 
Chapter 4 confirmed the previous research5 on per-0-acetylatcd neoglycolipids 
and the fragmentation pathway was re latively simple to determine. E li mination o f acet ic 
acid and ketene molecules were observed, resulting from the 0 -acetylated group present 
on the neoglycolipid carbohydrate. o C-glycoside ion-specie wa obscr ed, due to the 
protection o f the neoglycolipid be longing to the 0 -acety lated groups. 
Comparison o f the data from Chapters 3 and 4, regarding whether the per-0-
acetylated o r free-neoglyco lipids give ri e to the [C-glycoside+Hf ion-species w ithin the 
ES I-QIT mass spectrometer and the FT-IC R mass spectrometer, has been conducted by 
collaborators Gianluca Giorg i and Jon Am tc r.78 T he resul ts obta ined with the ESI-QIT, 
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FT-ICR-MS11 were identical to the results acquired using the QqToF-MS/ MS. The major 
point of comparison of the techniques was to observe the fo rmation in situ of the C-
glycoside ion-species with other cell collisions. The C-glyco ide ion-species was noted by 
both Gianluca Giorgi and Jon Amster. Compared to the ESI-QqToF techn ique, the ion 
tra p and Fourier-transform mass spectrometers are able to trap any ion before it 
fragmentation. The quality of the data79 with those techniques was definitely better than 
that obtained using the ESI-QqToF mass spectrometer. 
Interference of the 2-azido group, the partial 0-acetylation of the non-reducing 
end and the presence of the 4,6-0-benzylidene group on the azido-0-galactosam ine were 
observed in Chapter 5. The formation of a new ion-species was noticed under the [C-
glycoside+H-N2f even though the neoglycolipid was partially acetylated. The reason that 
this ion-species was present could be due to the fact that the free acetylated carbohydrate 
was linked directly to the linker attached to the cholesteryl group. However, it was not 
possible to fragment this ion-species during quasi-MS3 acquisition. 
Chapter 6 focused on the difference in the fragmentation observed with isomeric 
or anomeric neoglycolipid. It was noticed that a n a-anomer would produce ions with a 
hi gher intensity than a ~-anomer. Occurrence of the [C-glycoside+ l-1- 2l ' ion-species was 
observed for the family of 2-azido-neoglycolipids. It was possible to isolate this ion to 
determine its fragmentation pathway, contrary to the pat1ially 0-acetylated 2-azido-
neoglycolipids in Chapter 5. Differences in the intensity of the product ions were a lso 
observed with ~-L and ~-0 anomers. Finally, the constitutional isomers produced 
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different resul ts. orne product ions would be seen, favored by the linkage between the 
carbohydrate . 
Simple fragmentation of glycolipids was observed in Chapter 7. This allowed 
confirmation of the fragmentation of the carbohydrate moiety, and related it to the 
previous chapters. It was shown that no main difference existed in the fingerprint of the 
sugar moiety compared to the previous fingerprint of the carbohydrate moiety in the 
neoglycolipid . 
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Future work 
Future experiments should be conducted to confirm in each case if the cholesterol-
glycoside ion is either a weak ion or an ion-molecule complex. 
The analyses of the simple glycolipids 13-15 could be attempted by using Grant' s 
method77 with a MALDI-ToF. It would be interesting to see if hi s method can be applied 
to the series of glycolipids. 
An additional novel series of glycoconjugates, containing the cholesteryl could also 
be assessed by MALDI-ToF-MS, to be compared to the other techniques used (ESI-
QqToF, ES l-QlT, FT-ICR) which revealed the presence of the cholesteryl-glycoside ion. 
Finally, it was recently observed that the study ofthe neoglycoconj ugates by high-
resolution could affect the relative abundances of the product ions. tudying the CID-
MS/MS of the protonated molecules and the C-glycoside ion-molecule formation in the 
collision cell for the 2-deoxy-2-azido-neoglycolipids with high-resolution FT-1CR-MS11 
instrument is a must and would be of primordial interest. 
It could be of interest to synthesize a novel series of C-glycosides contain ing both 
the cholesteryl aglycon and 2-deoxy-2-acetamido- and 2-deoxy-2-azido-glucosamine to 
be studied using ES I-QqToF mass spectrometry in low and high-resolution, and compare 
it to the tandem mass spectrum data of the neoglycolipids, which gave a cholesteryl-
glycoside ion or ion-molecule complex structure similar to that of the C-glycoside. 
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This will be a formidable task to achieve as to our knowledge there arc no synthetic 
method existing that would allow such a synthesis. 
Article ba ed on the work described in this thesis regarding the azido 
neoglycolipid , the anomeric and isomeric effect and comparison with the QIT-MS11 and 
FT-ICR-M 11 will be subject of future publications. 
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Appendices 
TurbolonSpray 
Gas 1 of QSTAR XL connected to Neb gas 
Gas 2 of QSTAR XL connected to Turbo gas 
~~~~-~~~~r~~2-':i~.-I~X":: ~/~·<~ ' ' " 
NEB GAS TURBO GAS 
Gas 1 Gas 2 
Setting Value Setting Value 
(L/ (L/min) 
min) 
0 0.00 0 0.0 
10 0.62 10 L5 
20 1.16 20 2.5 
30 1.56 30 3.0 
40 1.95 40 4.0 
50 2.85 50 4.8 
55 3.03 60 1 5.5 
60 3.33 70 6.0 
70 3.77 80 6.5 
80 4.10 90 7.5 
90 4.35 
Appendix I: Flow conversion table for QSTAR XL (QSTAR XL System, Hardware Guide, Applied 
Biosystems, July 2002) 
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